Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 3836
interventional 3350
Observational 459
Registry 27

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 1393
Drug|Other 206
Drug|Radiation 167
Biological 156
Procedure 152
Biological|Drug 123
Drug|Procedure 121
Drug|placebo 114
Radiation 102
Biological|Drug|Other 96
Other 78
Device 65
Biological|Other 53
Drug|Procedure|Radiation 42
Drug|Other|Procedure 35
Drug|Other|placebo 28
Procedure|Radiation 28
Drug|Other|Radiation 24
Device|Drug 21
Diagnostic Test 19
Combination Product 17
Biological|Drug|Radiation 15
Drug|Other|Procedure|Radiation 15
Other|Procedure 14
Other|Radiation 14
Behavioral 12
Biological|Other|Radiation 12
Dietary Supplement 12
Biological|Drug|Procedure 11
Biological|Other|Procedure 11
Biological|Procedure 11
Behavioral|Other 9
Biological|Drug|Other|Radiation 9
Biological|placebo 9
Genetic 9
Biological|Drug|Other|placebo 8
Biological|Radiation 8
Device|Procedure 8
Biological|Drug|Other|Procedure 7
Biological|Drug|placebo 6
Combination Product|Drug 6
Dietary Supplement|placebo 6
Biological|Drug|Other|Procedure|Radiation 5
Device|Other 4
Drug|placebo|Procedure 4
Other|Procedure|Radiation 4
Behavioral|Drug 3
Biological|Other|placebo 3
Biological|Other|Procedure|Radiation 3
Device|Drug|Procedure 3
Device|Radiation 3
Dietary Supplement|Other 3
Drug|Genetic|Other|Procedure 3
Drug|placebo|Radiation 3
placebo|Procedure 3
Behavioral|Other|Procedure 2
Biological|Device 2
Biological|Device|Drug 2
Biological|Drug|placebo|Radiation 2
Biological|Drug|Procedure|Radiation 2
Device|placebo 2
Diagnostic Test|Drug 2
Dietary Supplement|Drug 2
Dietary Supplement|Drug|Other 2
Dietary Supplement|Other|placebo|Procedure 2
Drug|Genetic 2
Drug|Other|placebo|Procedure 2
Drug|Other|placebo|Radiation 2
Behavioral|Dietary Supplement 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Drug|placebo 1
Behavioral|Other|Procedure|Radiation 1
Behavioral|placebo 1
Behavioral|Radiation 1
Biological|Device|Drug|Other 1
Biological|Diagnostic Test 1
Biological|Dietary Supplement|Drug|Procedure|Radiation 1
Biological|Drug|Genetic 1
Biological|Drug|Other|placebo|Procedure 1
Biological|Drug|placebo|Procedure 1
Biological|Genetic 1
Biological|Procedure|Radiation 1
Combination Product|Other|Procedure 1
Combination Product|placebo 1
Combination Product|Procedure 1
Device|Drug|Radiation 1
Device|Other|Radiation 1
Diagnostic Test|Drug|Procedure 1
Diagnostic Test|Drug|Radiation 1
Dietary Supplement|Drug|placebo 1
Dietary Supplement|Drug|Procedure 1
Dietary Supplement|Other|Procedure 1
Dietary Supplement|Procedure 1
Dietary Supplement|Radiation 1
Drug|Genetic|Other|Radiation 1
Drug|Genetic|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 1526
China 459
France 116
Korea, Republic of 83
NA 83
Canada 78
Germany 61
United States|Canada 60
Taiwan 50
Italy 43
Netherlands 42
Japan 32
United Kingdom 27
Spain 26
Belgium 21
Hong Kong 20
Denmark 17
Australia 15
India 14
United States|Puerto Rico 12
Brazil 11
Russian Federation 10
Singapore 10
Austria 9
Switzerland 9
United States|Spain 9
Israel 8
Egypt 6
Norway 6
China|Korea, Republic of|Taiwan 5
Sweden 5
United States|Canada|Puerto Rico 5
United States|Germany 5
Austria|Germany 4
Japan|Korea, Republic of 4
United States|Canada|Korea, Republic of 4
Australia|New Zealand 3
Saudi Arabia 3
Thailand 3
United States|Belgium 3
United States|Canada|Japan|Korea, Republic of 3
United States|France|Spain 3
United States|Korea, Republic of 3
United States|South Africa 3
United States|Taiwan 3
United States|United Kingdom 3
Belgium|France 2
Czech Republic 2
Denmark|Sweden 2
Finland 2
France|Germany|Spain 2
Germany|Switzerland 2
Greece 2
Korea, Republic of|Taiwan 2
Netherlands|United Kingdom 2
Pakistan 2
Philippines 2
Sudan 2
United States|Australia 2
United States|Australia|Canada 2
United States|Australia|Canada|New Zealand|Puerto Rico 2
United States|Canada|Israel 2
United States|Canada|United Kingdom 2
United States|China 2
United States|China|Singapore 2
United States|France 2
United States|Germany|Italy 2
United States|Israel 2
United States|Japan 2
United States|Japan|Korea, Republic of 2
United States|Netherlands 2
United States|Peru 2
United States|Singapore 2
Algeria|Brazil|China|France|India|Indonesia|Italy|Korea, Republic of|Mexico|Morocco|Philippines|Thailand|Tunisia|Turkey 1
Algeria|Egypt|India|Jordan|Lebanon|Russian Federation|Saudi Arabia|South Africa|Thailand|Tunisia 1
Algeria|Morocco|Tunisia 1
Argentina 1
Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Lithuania|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Argentina|Australia|Austria|Brazil|Chile|China|Czech Republic|Estonia|Greece|Hong Kong|India|Ireland|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Pakistan|Poland|Russian Federation|Slovakia|Tunisia|Ukraine|United Kingdom 1
Argentina|Australia|Austria|Brazil|Chile|China|Czech Republic|Estonia|Italy|Korea, Republic of|Latvia|Lithuania|New Zealand|Pakistan|Poland|Russian Federation|Slovakia|Tunisia|Ukraine|United Kingdom 1
Argentina|Cuba|India|Indonesia|Pakistan|Philippines|South Africa|Thailand|Uruguay 1
Australia|Austria|Denmark|Germany|Netherlands|United Kingdom 1
Australia|Belgium|China|Germany|Japan|Singapore|Spain 1
Australia|Canada 1
Australia|Canada|Japan 1
Australia|New Zealand|Poland|Russian Federation|Thailand 1
Australia|Russian Federation 1
Austria|Belgium|Canada|Germany 1
Austria|Belgium|Czechia|Denmark|Germany|Ireland|Netherlands|United Kingdom 1
Austria|Belgium|Czechia|France|Germany|Italy|Spain|United Kingdom 1
Austria|Belgium|Finland|France|Italy|Sweden|United Kingdom 1
Austria|Bulgaria|Germany|Hungary|Poland|Romania|Slovakia|Spain|Switzerland|United Kingdom 1
Austria|Czech Republic|France|Germany|Russian Federation|United Kingdom 1
Austria|France|Germany 1
Austria|France|Germany|Hungary|Netherlands|Poland|Romania|United Kingdom 1
Austria|France|Germany|Switzerland 1
Austria|France|Italy|Poland 1
Austria|Germany|Korea, Republic of|Switzerland 1
Austria|Germany|Netherlands 1
Austria|Germany|Netherlands|Poland|Slovenia 1
Austria|Germany|Switzerland 1
Austria|Switzerland 1
Bangladesh 1
Belarus|Hungary|Poland|Russian Federation|Ukraine 1
Belgium|Bulgaria|Germany|Hungary|Latvia|Poland|Romania|Serbia|United Kingdom 1
Belgium|Canada|Australia|France|Ireland|Italy|Netherlands|New Zealand|Singapore|Switzerland|United Kingdom 1
Belgium|Canada|France|Spain|United Kingdom 1
Belgium|Czechia|France|Germany|Netherlands|Spain|United Kingdom 1
Belgium|Denmark 1
Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|France|Germany 1
Belgium|France|Germany|Italy|Poland|Spain 1
Belgium|France|Italy|United Kingdom 1
Belgium|France|Netherlands 1
Belgium|France|Netherlands|Spain|Switzerland|United Kingdom 1
Belgium|France|Switzerland|United Kingdom 1
Belgium|Germany|Italy|Spain|United Kingdom 1
Belgium|Italy 1
Belgium|Luxembourg 1
Belgium|United States|Australia 1
Belgium|United States|Canada|France|Italy|Korea, Republic of|Singapore|Spain|Taiwan 1
Bulgaria|Canada|India|Russian Federation|Slovakia|South Africa|Spain 1
Bulgaria|Romania|Russian Federation|Ukraine|United Kingdom 1
Canada|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Taiwan 1
China|France|Germany|Italy|Poland|Spain|Taiwan|United Kingdom 1
China|Hong Kong|Japan|Korea, Republic of|Singapore|Taiwan|Thailand 1
China|Hong Kong|Korea, Republic of|Malaysia|Taiwan 1
China|Hong Kong|Korea, Republic of|Taiwan 1
China|Hong Kong|Korea, Republic of|Taiwan|Thailand 1
China|Hong Kong|Singapore|Taiwan|Thailand 1
China|Japan|Korea, Republic of 1
China|Korea, Republic of 1
China|Korea, Republic of|Taiwan|Thailand 1
China|Singapore 1
China|Taiwan 1
China|Taiwan|Thailand 1
China|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|France|Germany|Greece|Hong Kong|Italy|Japan|Korea, Republic of|Mexico|New Zealand|Portugal|Romania|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
China|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Colombia|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Puerto Rico|Romania|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
China|United States|Australia|Belgium|Brazil|Canada|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine|Vietnam 1
Croatia 1
Croatia|Hong Kong|India|Korea, Republic of|Malaysia|Philippines|Poland|Serbia|Singapore|Sweden|Thailand 1
Cuba 1
Czech Republic|France|Netherlands|United Kingdom 1
Czech Republic|Germany|Netherlands 1
Czechia|France|Germany|Italy|Poland|Spain 1
Denmark|Finland|France|Italy|Japan|Norway|Spain|Sweden 1
Denmark|France|Germany|Greece|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Denmark|Germany|Norway|Sweden|United Kingdom 1
Finland|France|Germany|Italy|United Kingdom 1
France|Germany|Italy|Poland|United Kingdom 1
France|Germany|Italy|Spain 1
France|Greece|India|Peru|Spain 1
France|Korea, Republic of|Taiwan 1
France|Martinique 1
France|Monaco 1
France|Netherlands|Spain|United Kingdom 1
France|Spain 1
France|Switzerland 1
France|United Kingdom 1
France|United States|Austria|Canada|Germany|Italy|Mexico|Netherlands|Russian Federation|Spain 1
Germany|Hungary|Poland|Spain|Ukraine 1
Germany|Italy 1
Germany|Italy|Korea, Republic of|Spain 1
Germany|Italy|Spain 1
Germany|Netherlands 1
Germany|Spain 1
Germany|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|Croatia|France|Greece|Israel|Italy|Mexico|New Zealand|Peru|Poland|Romania|Russian Federation|Spain|Switzerland|United Kingdom 1
Germany|United States|Australia|France|Spain 1
Greece|Australia|Belarus|Brazil|Bulgaria|Chile|China|Colombia|Czechia|Georgia|Hungary|Jordan|Lebanon|Malaysia|Mexico|Philippines|Poland|Romania|Russian Federation|Spain|Taiwan|Thailand|Turkey|Ukraine 1
Greece|Israel|Italy 1
Greece|Spain|Switzerland 1
Hong Kong|Korea, Republic of 1
Hong Kong|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan|Thailand 1
Hong Kong|Korea, Republic of|Singapore|Taiwan 1
Hong Kong|Singapore 1
Hong Kong|Singapore|Taiwan 1
Hong Kong|Taiwan|Thailand 1
Hong Kong|United States|Belgium|Brazil|Czech Republic|Egypt|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Russian Federation|Singapore|South Africa|Spain|Switzerland|Taiwan|Thailand|Turkey|United Kingdom 1
Hungary|United States|Austria|France|Italy|Poland|Romania|Spain 1
India|Russian Federation|Ukraine 1
Indonesia 1
Ireland 1
Ireland|Sweden 1
Japan|Korea, Republic of|Taiwan|Hong Kong 1
Japan|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Colombia|Czech Republic|France|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Norway|Poland|Saudi Arabia|Slovakia|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Japan|United States|Argentina|Australia|Canada|China|France|Hong Kong|Italy|Korea, Republic of|Spain|Taiwan|Thailand 1
Japan|United States|Australia|Bosnia and Herzegovina|Brazil|Canada|Czechia|Denmark|France|Germany|Italy|Korea, Republic of|Mexico|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
Japan|United States|Australia|Brazil|Canada|China|France|Hong Kong|India|Italy|Korea, Republic of|Mexico|Russian Federation|Singapore|Spain|Taiwan|Thailand|Vietnam 1
Korea, Republic of|Malaysia|Myanmar|Singapore 1
Korea, Republic of|United Kingdom 1
Kuwait 1
Lithuania 1
Malaysia 1
Mexico 1
Mongolia 1
Netherlands|Norway|Spain 1
Netherlands|Spain|Switzerland 1
New Zealand 1
New Zealand|United Kingdom 1
Norway|Sweden 1
Palestinian Territory, occupied 1
Philippines|United States|Australia|Belgium|Canada|Denmark|France|Greece|Indonesia|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Thailand|United Kingdom 1
Poland 1
South Africa|United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Colombia|Czech Republic|France|Germany|Hong Kong|Hungary|India|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|Poland|Portugal|Russian Federation|Serbia|Singapore|Slovakia|Spain|Taiwan|Ukraine|United Kingdom 1
Spain|Taiwan|United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|France|Germany|Greece|Hong Kong|Israel|Italy|Korea, Republic of|New Zealand|Peru|Poland|Russian Federation|Singapore|South Africa|United Kingdom 1
Spain|United States|Australia|Austria|Belgium|Canada|China|France|Germany|Italy|Korea, Republic of|Singapore|Taiwan 1
Spain|United States|Belgium|Germany|Italy|United Kingdom 1
Spain|United States|France|Germany|Italy|United Kingdom 1
Taiwan|United States|Belgium|China|France|Germany|Italy|Japan|Korea, Republic of|Spain|United Kingdom 1
United Kingdom|United States|Argentina|Australia|Brazil|Chile|Czechia|Germany|Greece|Israel|Italy|Japan|Mexico|Poland|Romania|Russian Federation|Spain|Turkey 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Czechia|France|Germany|Italy|Japan|Mexico|Netherlands|Poland|Romania|Russian Federation|Singapore|Spain|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|France|Germany|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Czechia|France|Germany|Greece|Hong Kong|Italy|Japan|Korea, Republic of|New Zealand|Poland|Puerto Rico|Romania|Russian Federation|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Colombia|Czechia|Denmark|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Czechia|Finland|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Poland|Singapore|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Colombia|Czechia|France|Georgia|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Philippines|Poland|Romania|Russian Federation|Singapore|Spain|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|Denmark|Finland|France|Germany|Greece|Ireland|Israel|Italy|Japan|Norway|Poland|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Italy|Netherlands|New Zealand|Portugal|Spain|Sweden|Switzerland 1
United States|Argentina|Australia|Austria|Belgium|Brazil|China|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|China|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Philippines|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Austria|Canada|Chile|China|Denmark|Finland|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Chile|Croatia|Czechia|France|Georgia|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Spain|Taiwan|Ukraine 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czech Republic|France|Germany|Hong Kong|India|Italy|Japan|Korea, Republic of|Mexico|Poland|Puerto Rico|Russian Federation|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Colombia|France|Germany|Hong Kong|Korea, Republic of|Mexico|Philippines|Singapore|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Croatia|Czech Republic|Estonia|Greece|India|Israel|Italy|Latvia|Lithuania|Malaysia|Netherlands|Norway|Russian Federation|Slovenia|South Africa|Spain|Sweden|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|China|Denmark|France|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|New Zealand|Norway|Poland|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|Sweden 1
United States|Argentina|Australia|Brazil|Canada|Chile|Colombia|Czechia|Finland|France|Germany|Ireland|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Colombia|France|Germany|Greece|Hungary|Israel|Italy|Mexico|Norway|Portugal|Romania|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Australia|Brazil|Chile|China|Colombia|Hong Kong|Mexico|New Zealand|Peru|Russian Federation|Singapore 1
United States|Argentina|Australia|Canada|Czech Republic|Former Serbia and Montenegro|Germany|Greece|Hungary|Italy|Latvia|Lithuania|Mexico|Netherlands|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom| 1
United States|Argentina|Australia|Canada|France|Germany|Greece|Ireland|Israel|Korea, Republic of|Netherlands|Norway|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Austria|Belgium|Brazil|Canada|France|Germany|Israel|Italy|Japan|Korea, Republic of|Lebanon|Mexico|Netherlands|Norway|Poland|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Austria|Belgium|Brazil|Czechia|Denmark|France|Germany|Greece|Israel|Italy|Japan|Mexico|Russian Federation|South Africa|Spain|Sweden|Switzerland 1
United States|Argentina|Austria|Brazil|Bulgaria|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Slovakia|Spain|Taiwan|Turkey|Ukraine 1
United States|Argentina|Austria|Canada|Chile|China|Denmark|France|Germany|Greece|Hungary|India|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Portugal|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Austria|Canada|Chile|Czechia|France|Germany|Hungary|Spain|United Kingdom 1
United States|Argentina|Austria|Chile|Czechia|France|Greece|Italy|Mexico|Poland|Portugal|Romania|Russian Federation|Spain 1
United States|Argentina|Belgium|Brazil|Canada|France|Germany|Israel|Italy|Netherlands|Spain|Turkey 1
United States|Argentina|Belgium|Croatia|France|Spain 1
United States|Argentina|Brazil|Bulgaria|China|Russian Federation 1
United States|Argentina|Brazil|Canada|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Bulgaria|Canada|Chile|Czechia|France|Hungary|India|Italy|Poland|Romania|Russian Federation|Serbia|Ukraine|United Kingdom 1
United States|Argentina|Canada|Hong Kong|Russian Federation|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Czech Republic|Finland|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Norway|Philippines|Portugal|Romania|Spain|Sweden|Switzerland|Taiwan|Thailand 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Poland|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Japan|Czechia|France|Germany|Hong Kong|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Peru|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey 1
United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Czechia|France|Germany|Israel|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Chile|Czechia|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|Denmark|Finland|France|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Portugal|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|France|Germany|Greece|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Spain|Taiwan|Thailand 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Germany|Greece|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Japan|Netherlands|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Greece|Italy|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Brazil|Canada|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Peru|Puerto Rico|Taiwan|Thailand|Turkey 1
United States|Australia|Austria|Canada|Denmark|France|Germany|Hong Kong|Italy|Korea, Republic of|Luxembourg|Netherlands|Norway|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Canada|France|Greece|Indonesia|Italy|Korea, Republic of|Philippines|Singapore|Spain|Sweden|Switzerland|Thailand 1
United States|Australia|Austria|Canada|Turkey|Hungary|Italy|Japan|Korea, Republic of|Poland|Portugal|Spain|Taiwan|United Kingdom 1
United States|Australia|Austria|France|Germany|Italy|Netherlands|Sweden 1
United States|Australia|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Czechia|Estonia|Finland|Georgia|Greece|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Spain|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovenia|South Africa|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Chile|France|Germany|Hong Kong|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|New Zealand|Spain|Taiwan|Thailand|Turkey 1
United States|Australia|Belgium|Brazil|Canada|China|France|Germany|Hungary|India|Italy|Japan|Korea, Republic of|Poland|Portugal|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|France|Germany|Greece|Ireland|Italy|Japan|New Zealand|Poland|Russian Federation|Spain|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Greece|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|China|Czechia|Finland|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|China|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Malaysia|Philippines|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|France|Georgia|Germany|Hungary|Israel|Korea, Republic of|Malaysia|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Romania|Russian Federation|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Greece|Hungary|Italy|Spain|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Hong Kong|Ireland|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Belgium|China|Czech Republic|Hong Kong|Israel|Taiwan 1
United States|Australia|Belgium|China|Czechia|France|Germany|Italy|Japan|Korea, Republic of|Poland|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Romania|Russian Federation|Spain|Taiwan|Ukraine 1
United States|Australia|Belgium|France|Germany|Israel|Italy|New Zealand|Poland|Spain|Switzerland 1
United States|Australia|Belgium|France|Germany|United Kingdom 1
United States|Australia|Brazil|Canada|Chile|France|Germany|Hungary|Ireland|Italy|Japan|Korea, Republic of|New Zealand|Norway|Russian Federation|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Brazil|Canada|France|Germany|Italy|Poland|Russian Federation|Spain|United Kingdom 1
United States|Australia|Canada|Chile|China|Colombia|France|Germany|Ireland|Italy|Japan|Korea, Republic of|Mexico|New Zealand|Poland|Russian Federation|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia|Canada|China|Czechia|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|China|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|New Zealand|Portugal|Singapore|Taiwan|Thailand|United Kingdom 1
United States|Australia|Canada|China|Germany|Ireland|Italy|Japan|Korea, Republic of|Netherlands|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Canada|China|Hong Kong|Puerto Rico|Singapore|Taiwan 1
United States|Australia|Canada|Czechia|Finland|Greece|Italy|Korea, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Spain|Switzerland|United Kingdom 1
United States|Australia|Canada|Denmark|France|Germany|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Canada|France|Germany|Israel|Mexico|Norway|Spain|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy|Japan|Netherlands|Poland|Spain 1
United States|Australia|Canada|France|Germany|Italy|Netherlands|Poland|United Kingdom 1
United States|Australia|Canada|France|Italy|New Zealand|Spain|Sweden 1
United States|Australia|Canada|Hong Kong|Korea, Republic of 1
United States|Australia|Canada|Japan|New Zealand|Puerto Rico|Saudi Arabia 1
United States|Australia|Canada|Japan|Norway 1
United States|Australia|Canada|Puerto Rico 1
United States|Australia|Chile 1
United States|Australia|Chile|Colombia|Denmark|Israel|Japan|Korea, Republic of|New Zealand|Puerto Rico|Taiwan|Turkey|Ukraine 1
United States|Australia|China|Singapore|Taiwan 1
United States|Australia|France|Germany|Italy|Japan|Spain 1
United States|Australia|France|Germany|Italy|New Zealand|Spain 1
United States|Australia|France|Germany|Italy|New Zealand|Spain|United Kingdom 1
United States|Australia|France|Italy|Japan 1
United States|Australia|France|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Australia|Korea, Republic of 1
United States|Australia|Korea, Republic of|Taiwan 1
United States|Australia|Portugal 1
United States|Australia|Singapore 1
United States|Australia|Taiwan 1
United States|Austria|Belarus|Bosnia and Herzegovina|Canada|Croatia|France|Hungary|India|Israel|Italy|Malaysia|Poland|Romania|Russian Federation|Serbia|Spain|Sri Lanka|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Greece|Italy|Spain|Switzerland 1
United States|Austria|Belgium|Canada|France|Israel|Norway|Poland|Spain|Sweden|United Kingdom 1
United States|Austria|Belgium|China|Czechia|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|New Zealand|Singapore|Spain|Switzerland|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Austria|Belgium|Czechia|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|New Zealand|Spain|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Austria|Belgium|Egypt|France|Germany|Hungary|Italy|Lebanon|Spain|Turkey 1
United States|Austria|Czechia|Germany|Lithuania|Poland|Slovakia|Taiwan 1
United States|Austria|France|Germany|Italy|Japan|Korea, Republic of|Spain 1
United States|Austria|Israel|Korea, Republic of|Norway|Spain 1
United States|Belgium|Canada|China|France|Germany|Italy|Korea, Republic of|Netherlands|Singapore|Spain|United Kingdom 1
United States|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Poland|Spain|United Kingdom 1
United States|Belgium|Canada|Czechia|France|Georgia|Germany|Hungary|Israel|Korea, Republic of|Malaysia|Spain|Taiwan|United Kingdom 1
United States|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Belgium|Canada|Denmark|Netherlands|Switzerland 1
United States|Belgium|Canada|France|Germany|Greece|Hungary|Italy|Poland|Russian Federation|Slovenia|Spain|United Kingdom 1
United States|Belgium|Canada|France|Greece|Hungary|Iceland|Israel|Italy|Netherlands|Poland|Portugal|Spain|United Kingdom 1
United States|Belgium|Canada|France|Italy|Poland|Spain|United Kingdom 1
United States|Belgium|Canada|Germany|Italy 1
United States|Belgium|Canada|Hong Kong|Korea, Republic of|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|Canada|Italy|Spain 1
United States|Belgium|Canada|Spain 1
United States|Belgium|China|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Slovakia|Taiwan|United Kingdom 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|Czech Republic|France|Hungary|Poland|Slovakia|United Kingdom 1
United States|Belgium|Czech Republic|Germany|India|Poland|Serbia|Taiwan 1
United States|Belgium|Denmark|France|Germany|Israel|Italy|Japan|Netherlands|Spain|United Kingdom 1
United States|Belgium|Finland|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Spain|Switzerland 1
United States|Belgium|Finland|France|Italy|Japan|Spain 1
United States|Belgium|France|Germany 1
United States|Belgium|France|Germany|Greece|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Belgium|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|New Zealand|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Belgium|France|Germany|Italy|Spain|United Kingdom 1
United States|Belgium|France|Greece|Italy 1
United States|Belgium|France|Israel|Italy 1
United States|Belgium|France|Italy|Spain|United Kingdom 1
United States|Belgium|France|Spain 1
United States|Belgium|France|Spain|United Kingdom 1
United States|Belgium|Italy|Spain|Ukraine|United Kingdom 1
United States|Brazil|Canada|China|France|Germany|Hong Kong|India|Italy|Japan|Korea, Republic of|Russian Federation|Spain|Taiwan|Thailand|Ukraine|Vietnam 1
United States|Brazil|France|Italy|Korea, Republic of|Russian Federation|Ukraine 1
United States|Bulgaria|Canada|Chile|Czech Republic|France|Hungary|India|Italy|Poland|Romania|Russian Federation|Serbia|Ukraine|United Kingdom 1
United States|Bulgaria|Hungary|Romania 1
United States|Bulgaria|Israel|Romania|Serbia 1
United States|Bulgaria|Korea, Republic of|Malaysia|Poland|Russian Federation|Ukraine 1
United States|Canada|China 1
United States|Canada|China|Germany|Hong Kong|Italy|Korea, Republic of|Malaysia|Philippines|Singapore|Spain|Taiwan|Thailand|Vietnam 1
United States|Canada|China|Hong Kong|Italy|Japan|Korea, Republic of|Malaysia|Philippines|Taiwan|Thailand 1
United States|Canada|China|Korea, Republic of|Singapore|Taiwan 1
United States|Canada|Colombia|France|Ireland|Korea, Republic of|Mexico|Puerto Rico|Saudi Arabia|Spain 1
United States|Canada|Czechia|France|Italy|Poland|Spain|United Kingdom 1
United States|Canada|Denmark|France|Germany|Italy|Korea, Republic of|Spain|United Kingdom 1
United States|Canada|Finland|Italy 1
United States|Canada|France 1
United States|Canada|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Puerto Rico|Singapore|Spain|Taiwan|United Kingdom 1
United States|Canada|France|Germany|Hong Kong|Korea, Republic of|Taiwan 1
United States|Canada|France|Germany|Italy|Netherlands|United Kingdom 1
United States|Canada|France|Germany|Italy|Spain|United Kingdom 1
United States|Canada|France|Germany|Netherlands|United Kingdom 1
United States|Canada|France|Greece|Italy|Singapore|Spain|Taiwan|Tunisia 1
United States|Canada|France|Israel|Netherlands|United Kingdom 1
United States|Canada|France|Japan|Korea, Republic of|Poland|Spain|Taiwan|Turkey 1
United States|Canada|Germany|Hong Kong|Italy|Japan|Spain|Taiwan 1
United States|Canada|Germany|Israel|Italy|Spain 1
United States|Canada|Hong Kong|Italy|Korea, Republic of|Puerto Rico|Spain|Taiwan|United Kingdom 1
United States|Canada|Hungary|India|Netherlands|Poland|Serbia|United Kingdom 1
United States|Canada|Ireland|Peru|South Africa 1
United States|Canada|Ireland|Saudi Arabia 1
United States|Canada|Japan|Korea, Republic of|Puerto Rico 1
United States|Canada|Korea, Republic of|Puerto Rico 1
United States|Canada|Korea, Republic of|Spain|Taiwan 1
United States|Canada|Netherlands|Russian Federation 1
United States|Canada|Singapore 1
United States|Canada|Singapore|Taiwan 1
United States|Canada|Spain 1
United States|Canada|Switzerland 1
United States|Chile|China|Denmark|Estonia|France|Hong Kong|Hungary|Italy|Korea, Republic of|Russian Federation|Taiwan|Turkey 1
United States|Chile|Colombia|Finland|Korea, Republic of|Norway|Russian Federation|Spain|Turkey|Ukraine 1
United States|China|Czechia|France|Germany|Italy|Japan|Poland|Spain|Taiwan|United Kingdom 1
United States|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|China|France|Hong Kong|Singapore 1
United States|China|France|Hong Kong|Singapore|Taiwan|Thailand 1
United States|China|Hong Kong|Italy|Japan|Korea, Republic of|Singapore|Spain|Taiwan 1
United States|China|Hong Kong|Taiwan 1
United States|China|Italy|Korea, Republic of|Taiwan|United Kingdom 1
United States|China|Japan|Singapore 1
United States|Czechia|France|Germany|Italy|Poland|Romania|Spain|United Kingdom 1
United States|Czechia|France|Hungary|Latvia|Poland|Spain|Sweden|United Kingdom 1
United States|Czechia|France|Italy|Poland|Serbia|Spain 1
United States|Czechia|Germany|Japan|Russian Federation|Spain 1
United States|Czechia|Hungary|Italy|Japan|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|Ukraine 1
United States|Czechia|Hungary|United Kingdom 1
United States|Czechia|Poland|Spain|United Kingdom 1
United States|Denmark|France|Germany 1
United States|Denmark|France|United Kingdom 1
United States|France|Germany 1
United States|France|Germany|Greece|Netherlands|Sweden|Switzerland 1
United States|France|Germany|Hungary|Italy|Netherlands|Norway|Poland|Romania|Russian Federation|United Kingdom 1
United States|France|Germany|Israel|Netherlands|Spain 1
United States|France|Germany|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
United States|France|Germany|Japan|Spain|United Kingdom 1
United States|France|Germany|Poland|Russian Federation|Ukraine|United Kingdom 1
United States|France|Germany|Spain 1
United States|France|Germany|Spain|United Kingdom 1
United States|France|Greece|Korea, Republic of|Spain|United Kingdom 1
United States|France|Hong Kong|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan 1
United States|France|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|Taiwan|Turkey 1
United States|France|Italy|Japan|Russian Federation|Spain|United Kingdom 1
United States|France|Italy|Spain 1
United States|France|Korea, Republic of|Spain|Turkey 1
United States|France|Netherlands|Spain 1
United States|France|Taiwan|United Kingdom 1
United States|Germany|Hong Kong|Japan 1
United States|Germany|Hungary|Sweden|Switzerland 1
United States|Germany|Poland|Puerto Rico|Romania|Russian Federation|Ukraine 1
United States|Hong Kong|Korea, Republic of|Taiwan 1
United States|Hong Kong|Singapore|Taiwan 1
United States|Hong Kong|Taiwan 1
United States|Hungary|Argentina|Australia|Canada|Denmark|France|Germany|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Hungary|Poland|Russian Federation|Serbia|Spain|Ukraine 1
United States|India|United Kingdom 1
United States|Israel|Spain 1
United States|Italy|Korea, Republic of|Poland|Spain 1
United States|Italy|Spain 1
United States|Italy|Taiwan|United Kingdom 1
United States|Japan|Australia|Austria|Belgium|Canada|China|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Korea, Republic of|Poland|Portugal|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Japan|Korea, Republic of|Spain|Taiwan 1
United States|Japan|Korea, Republic of|Taiwan 1
United States|Korea, Republic of|Spain|United Kingdom 1
United States|Korea, Republic of|Ukraine|United Kingdom 1
United States|Malaysia|Singapore|Taiwan|Thailand 1
United States|Mexico 1
United States|Norway|United Kingdom 1
United States|Puerto Rico|South Africa 1
United States|Singapore|Taiwan|United Kingdom 1
United States|United Kingdom|Argentina|Australia|Brazil|Canada|Denmark|France|Germany|Hong Kong|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Spain|Taiwan|Thailand|Turkey 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 1760
2 220
3 172
4 99
5 96
6 71
7 66
8 59
9 41
10 50
11 37
12 22
13 31
14 25
15 25
16 18
17 19
18 12
19 10
20 17
21 13
22 16
23 15
24 13
25 9
26 11
27 5
28 15
29 8
30 6
31 2
32 6
33 8
34 4
35 10
36 6
37 6
38 6
39 7
40 5
41 6
42 4
43 5
44 4
45 2
48 1
49 6
51 6
52 1
53 4
54 2
55 4
57 2
58 3
59 3
60 2
61 3
62 2
63 1
64 3
65 2
66 2
67 2
68 1
69 1
70 1
71 1
72 3
73 1
75 4
76 3
77 2
78 2
79 1
81 1
82 1
84 2
86 2
87 1
91 3
92 3
93 2
94 2
95 2
96 1
97 2
98 1
100 1
101 2
103 2
104 2
105 1
106 2
107 1
108 5
110 1
111 1
112 1
113 3
116 1
119 1
120 1
121 1
122 1
124 2
125 2
127 1
128 1
130 1
131 3
133 1
134 3
136 1
141 4
142 3
143 2
144 2
146 1
147 1
151 1
153 1
154 2
156 2
160 2
161 3
163 1
165 1
169 1
172 3
173 3
177 1
178 1
180 1
181 1
182 1
186 2
187 1
188 3
189 2
191 2
192 2
193 1
194 2
199 2
204 2
205 2
206 1
214 1
218 2
220 1
222 1
224 2
225 2
227 2
228 1
230 1
232 1
233 2
234 1
235 1
236 1
240 1
241 1
251 1
252 1
259 1
262 1
272 2
276 1
281 1
295 1
301 1
302 1
308 1
315 1
320 1
323 1
333 1
337 1
354 1
358 1
362 2
367 1
368 1
369 1
374 1
390 1
395 1
410 1
416 1
418 1
428 1
432 1
433 1
439 1
453 1
468 1
480 1
488 1
493 1
503 1
508 2
516 1
526 1
533 1
534 1
538 1
549 1
559 1
573 1
587 1
597 1
620 1
632 1
640 1
663 2
672 1
673 1
687 1
718 1
721 1
740 1
756 1
781 1
789 1
797 1
798 1
815 1
816 1
858 1
860 1
873 1
877 1
892 1
931 1
938 1
987 1
993 1
1004 1
1021 1
1024 1
1065 1
1084 1
1111 1
1157 1
1175 1
1207 1
1268 1
1329 1
1498 2
1583 1

Phase

Phase Study_Count
Phase 2 1447
Phase 1 572
N/A 429
Phase 3 398
Phase 1/Phase 2 334
Early Phase 1 57
Phase 4 57
Phase 2/Phase 3 56

Number of Arms

Number_of_Arms Count_of_Studies
1 1688
2 1152
3 172
4 94
5 34
6 17
7 7
8 8
9 4
10 1
11 1
14 2
15 2
18 2
24 1
25 1
37 1
NA 163

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 2.0000 1.0000 1.00000 1.00000 1.00000 9.0000 1.0000 1
1st Qu. 13.0000 30.0000 18.00000 28.00000 30.00000 70.7500 186.0000 44
Median 20.0000 75.0000 28.00000 48.00000 50.00000 130.5000 360.0000 100
Mean 33.4386 636.7366 47.13509 83.85586 83.27519 453.7857 495.8401 141
3rd Qu. 35.0000 180.0000 45.00000 90.00000 94.00000 400.5000 627.5000 197
Max. 300.0000 154900.0000 1260.00000 1732.00000 6452.00000 10000.0000 10000.0000 954

Trial Group Type

group_type Group_Count
Experimental 4238
Active Comparator 787
Placebo Comparator 192
Other 173
NA 163
No Intervention 106
Sham Comparator 10

Intervention Model

intervention_model Study_Count
Single Group Assignment 1865
Parallel Assignment 1319
Sequential Assignment 81
Crossover Assignment 34
NA 29
Factorial Assignment 22

Primary Purpose

primary_purpose Study_Count
Treatment 2973
Diagnostic 150
Supportive Care 62
Prevention 61
Other 34
Basic Science 22
NA 20
Health Services Research 14
Screening 12
Device Feasibility 2

Observational Studies

Studies by Country

Country Study_Count
United States 112
NA 46
China 45
France 40
Germany 28
Canada 17
Spain 15
Japan 12
Korea, Republic of 11
Italy 10
Netherlands 10
Belgium 8
Taiwan 8
Sweden 7
United Kingdom 7
Egypt 6
Hong Kong 5
Switzerland 5
Singapore 4
Turkey 4
Denmark 3
Austria|Germany 2
Czech Republic 2
Czechia 2
Greece 2
Israel 2
Russian Federation 2
Algeria|Egypt 1
Argentina|Austria|China|Colombia|Czech Republic|France|Germany|Greece|Indonesia|Korea, Republic of|Mexico|Netherlands|Philippines|Poland|Russian Federation|Slovakia|Slovenia|Sweden 1
Argentina|Colombia 1
Argentina|France 1
Australia 1
Australia|China|Hong Kong|Japan|Korea, Republic of|New Zealand|Singapore|Taiwan|Thailand 1
Austria 1
Austria|Belgium|Czechia|France|Germany|Greece|Italy|Netherlands|Poland|Spain|United Kingdom 1
Austria|Belgium|France|Greece|Italy|Netherlands|Spain|United Kingdom 1
Austria|Brazil|Canada|China|Czechia|Denmark|Egypt|France|Greece|Hong Kong|Hungary|India|Indonesia|Israel|Japan|Kazakhstan|Korea, Republic of|Mexico|Netherlands|Pakistan|Poland|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Vietnam 1
Bangladesh 1
Belgium|France 1
Belgium|Netherlands 1
Brazil 1
China|Hong Kong|Japan 1
Croatia 1
Czechia|Germany|Poland|Spain|Switzerland|United Kingdom 1
France|Germany|Italy|United Kingdom 1
Germany|Switzerland 1
India 1
Israel|United States|Argentina|Austria|Belgium|Colombia|Estonia|Finland|Germany|Greece|Hungary|Italy|Lebanon|Pakistan|Spain|Taiwan|Turkey|United Kingdom 1
Kenya 1
Malawi 1
Malaysia|Philippines|Singapore|Thailand 1
Martinique 1
Mexico 1
Netherlands|Switzerland 1
Norway 1
Peru|Uruguay 1
Poland 1
Romania 1
Slovakia 1
Taiwan|Thailand 1
Thailand 1
United States|Argentina|Austria|Belgium|Canada|China|Denmark|Egypt|France|Greece|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Saudi Arabia|Spain|Sweden|Taiwan|Thailand|Turkey 1
United States|Canada 1
United States|Canada|China|Colombia|Croatia|Czech Republic|Finland|France|Greece|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Japan|Kazakhstan|Korea, Republic of|Libyan Arab Jamahiriya|Malaysia|Mexico|Norway|Pakistan|Philippines|Portugal|Qatar|Romania|Russian Federation|Singapore|Slovakia|Spain|Sweden|Syrian Arab Republic|Thailand|Ukraine|United Arab Emirates|Uruguay|Venezuela|Vietnam 1
United States|Canada|Hong Kong 1
United States|China 1
United States|Denmark|Finland|Italy|Portugal|United Kingdom 1
United States|France|Germany|Italy|Netherlands|Saudi Arabia|Switzerland|Turkey 1
United States|France|Germany|Italy|Spain 1
United States|France|Germany|Italy|Spain|Taiwan|Thailand 1
United States|Germany|Greece|Italy|Japan|Korea, Republic of|Spain 1

Sites per Study

Site_count Study_Count
1 345
2 22
3 12
4 8
5 7
6 4
7 5
8 3
9 1
10 3
11 1
12 1
13 3
14 3
15 1
16 3
17 2
18 4
19 1
21 1
23 1
27 1
28 1
30 1
31 1
34 3
37 2
41 1
42 1
46 1
52 1
57 2
60 1
66 1
75 2
82 1
108 1
110 1
144 2
167 1
182 1
187 1
231 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 52.000
Median 134.000
Mean 2251.838
3rd Qu 403.000
Max 741379.000

Observation Model

observational_model Study_Count
Cohort 273
Case-Only 89
Case-Control 36
Other 24
NA 17
Case Control 11
Ecologic or Community 4
Family-Based 3
Defined Population, Natural History 2

Time Perspective

time_perspective Study_Count
Prospective 307
Retrospective 106
Cross-Sectional 23
Other 13
NA 7
Cross-Sectional, Prospective 1
Longitudinal, Prospective 1
Longitudinal, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
United States 5
Italy 4
China 3
Germany 3
NA 3
Spain 3
Korea, Republic of 2
Argentina 1
France 1
Norway 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 20
2 1
5 2
6 1
15 1
25 1
27 1

Enrollment Metrics

Measure Registries
Min 20.00
1st Qu 105.50
Median 306.00
Mean 1484.63
3rd Qu 1500.00
Max 10000.00

Registry Model

observational_model Study_Count
Cohort 18
Case-Only 5
Case-Control 2
Other 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 25
Other 1
NA 1

Follow-up

target_duration Study_Count
3 Years 5
5 Years 4
10 Years 3
3 Months 2
36 Months 2
12 Months 1
15 Years 1
2 Years 1
24 Months 1
25 Years 1
3 Days 1
4 Years 1
6 Years 1
62 Months 1
7 Years 1
9 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04216732 Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management https://ClinicalTrials.gov/show/NCT04216732 Recruiting M.D. Anderson Cancer Center 2022-09-01
NCT03408769 Metastatic Breast Carcinoma and Women Sexual Quality of Life https://ClinicalTrials.gov/show/NCT03408769 Completed Institut de Cancérologie de Lorraine 2018-04-04
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study https://ClinicalTrials.gov/show/NCT03405909 Recruiting University Hospital Erlangen 2020-02-29
NCT03370861 How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes https://ClinicalTrials.gov/show/NCT03370861 Recruiting Washington University School of Medicine 2022-12-31
NCT02024035 Protocole Advanced RadioTherapy ORL https://ClinicalTrials.gov/show/NCT02024035 Completed Centre Leon Berard 2012-03-31
NCT04245410 Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT04245410 Recruiting Universidad de Extremadura 2020-03-01
NCT03364907 Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy https://ClinicalTrials.gov/show/NCT03364907 Active, not recruiting Radboud University 2019-06-08
NCT04106349 Observational Real-life Study of Cabozantinib in Advanced Renal Cell Carcinoma (RCC) https://ClinicalTrials.gov/show/NCT04106349 Recruiting Ipsen 2023-01-30
NCT03822988 ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS https://ClinicalTrials.gov/show/NCT03822988 Recruiting Central Hospital, Nancy, France 2019-06-20
NCT03356535 Metabolic Signature of Healthy Lifestyle and HCC https://ClinicalTrials.gov/show/NCT03356535 Completed International Agency for Research on Cancer 2017-09-15
NCT03331874 RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03331874 Recruiting Norfolk and Norwich University Hospitals NHS Foundation Trust 2019-12-31
NCT03325738 Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study https://ClinicalTrials.gov/show/NCT03325738 Completed Centre Antoine Lacassagne 2017-06-30
NCT03314051 Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA https://ClinicalTrials.gov/show/NCT03314051 Completed Taichung Veterans General Hospital 2013-05-01
NCT03305133 Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) https://ClinicalTrials.gov/show/NCT03305133 Completed Groupe Francais De Pneumo-Cancerologie 2018-09-14
NCT03295006 A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC https://ClinicalTrials.gov/show/NCT03295006 Recruiting BTG International Inc. 2019-11-30
NCT03289273 Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) https://ClinicalTrials.gov/show/NCT03289273 Active, not recruiting Bayer 2022-02-01
NCT03296826 Prospective Cohort Study of Variant Carriers With BRCA1 or BRCA2 https://ClinicalTrials.gov/show/NCT03296826 Recruiting Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2032-03-31
NCT03290001 The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03290001 Recruiting Sun Yat-sen University 2022-09-20
NCT03291028 Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT03291028 Recruiting Fox Chase Cancer Center 2020-12-31
NCT03290989 Itch and Pain Characteristics in Skin Carcinomas https://ClinicalTrials.gov/show/NCT03290989 Completed University Hospital, Brest 2015-04-01
NCT03253939 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer https://ClinicalTrials.gov/show/NCT03253939 Completed Hospices Civils de Lyon 2017-07-01
NCT03256877 Detecting Transitional Cell Carcinoma From Haematuria https://ClinicalTrials.gov/show/NCT03256877 Completed Hull University Teaching Hospitals NHS Trust 2018-05-28
NCT03254121 Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response https://ClinicalTrials.gov/show/NCT03254121 Recruiting Karolinska Institutet 2021-01-01
NCT03240835 The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients https://ClinicalTrials.gov/show/NCT03240835 Active, not recruiting Sun Yat-sen University 2018-12-31
NCT03226886 TRACERx Renal (TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx)) https://ClinicalTrials.gov/show/NCT03226886 Recruiting Royal Marsden NHS Foundation Trust 2023-09-01
NCT03211377 Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma https://ClinicalTrials.gov/show/NCT03211377 Recruiting Anyang Tumor Hospital 2019-03-29
NCT03200171 Effect of DAAs on Behavior of HCC in HCV Patients https://ClinicalTrials.gov/show/NCT03200171 Recruiting Al-Azhar University 2019-08-31
NCT03197155 Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence https://ClinicalTrials.gov/show/NCT03197155 Completed Hospices Civils de Lyon 2017-01-31
NCT03162198 Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03162198 Completed Institute of Liver and Biliary Sciences, India 2018-10-31
NCT03163186 Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial). https://ClinicalTrials.gov/show/NCT03163186 Completed Medical University of South Carolina 2016-04-20
NCT03160209 HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi https://ClinicalTrials.gov/show/NCT03160209 Recruiting UNC Lineberger Comprehensive Cancer Center 2020-07-31
NCT03161145 A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread https://ClinicalTrials.gov/show/NCT03161145 Completed Bristol-Myers Squibb 2017-08-31
NCT03140176 Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy. https://ClinicalTrials.gov/show/NCT03140176 Recruiting Pfizer 2020-12-30
NCT03137706 Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer https://ClinicalTrials.gov/show/NCT03137706 Recruiting University of Southern California 2021-02-14
NCT03132727 Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03132727 Completed Hospices Civils de Lyon 2019-11-22
NCT03109457 Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03109457 Completed Cairo University 2018-02-07
NCT03091465 Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib https://ClinicalTrials.gov/show/NCT03091465 Completed Spanish Oncology Genito-Urinary Group 2017-04-17
NCT03092830 Molecular Characterization of Cutaneous Tumors https://ClinicalTrials.gov/show/NCT03092830 Recruiting Rabin Medical Center 2020-08-07
NCT03092739 A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens https://ClinicalTrials.gov/show/NCT03092739 Completed Hoffmann-La Roche 2018-01-08
NCT03088423 HCC Response Assessment by MRI After SBRT https://ClinicalTrials.gov/show/NCT03088423 Completed Institut de Cancérologie de Lorraine 2013-04-01
NCT03053661 Immune Response Evaluation to Curative Conventional Therapy https://ClinicalTrials.gov/show/NCT03053661 Active, not recruiting University of Ulm 2020-08-31
NCT03053596 LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) https://ClinicalTrials.gov/show/NCT03053596 Completed Terumo Europe N.V. 2019-04-01
NCT03034850 Thrombin Generation and Platelet Activation in CRS/HIPEC https://ClinicalTrials.gov/show/NCT03034850 Completed Ziekenhuis Oost-Limburg 2016-07-31
NCT03013920 CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT03013920 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-04-30
NCT03010150 Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT03010150 Recruiting M.D. Anderson Cancer Center 2019-12-31
NCT02990351 Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt https://ClinicalTrials.gov/show/NCT02990351 Completed Ain Shams University 2015-12-31
NCT03232593 A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) https://ClinicalTrials.gov/show/NCT03232593 Recruiting Hoffmann-La Roche 2023-01-11
NCT02940639 Real-Life Efficacy and Safety of Nivolumab in Patients With Advanced/Metastatic Renal Cell Carcinoma After Prior Therapy https://ClinicalTrials.gov/show/NCT02940639 Recruiting Bristol-Myers Squibb 2024-10-31
NCT02941861 Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery https://ClinicalTrials.gov/show/NCT02941861 Completed Chulabhorn Hospital 2016-08-31
NCT02908178 Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ https://ClinicalTrials.gov/show/NCT02908178 Completed Yale University 2018-06-01
NCT02880306 Hepatocellular Carcinoma and Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02880306 Completed Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 2016-03-31
NCT02879968 Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer https://ClinicalTrials.gov/show/NCT02879968 Completed Prince of Songkla University 2018-08-31
NCT02878109 DCE-MRI for Assessment of Response to TACE of HCC https://ClinicalTrials.gov/show/NCT02878109 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2018-12-31
NCT02854228 PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon https://ClinicalTrials.gov/show/NCT02854228 Recruiting Hospices Civils de Lyon 2015-12-31
NCT02848768 Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02848768 Completed Rennes University Hospital 2015-03-31
NCT02852343 One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT02852343 Completed Rennes University Hospital 2016-12-21
NCT02848638 Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization https://ClinicalTrials.gov/show/NCT02848638 Completed University of Washington 2016-03-31
NCT02791750 5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma https://ClinicalTrials.gov/show/NCT02791750 Completed Institut de Cancérologie de Lorraine 2017-06-03
NCT02785835 Hepatocellular Carcinoma in HIV-infected Patients https://ClinicalTrials.gov/show/NCT02785835 Recruiting Hospital Universitario de Valme 2016-12-31
NCT02781389 Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions https://ClinicalTrials.gov/show/NCT02781389 Active, not recruiting University Hospital, Essen 2021-04-30
NCT02778191 Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT02778191 Completed University Medical Center Groningen 2017-03-31
NCT02776644 Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan https://ClinicalTrials.gov/show/NCT02776644 Completed Pfizer 2017-12-30
NCT02757846 Radiomics of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02757846 Enrolling by invitation Chinese Academy of Sciences 2022-03-31
NCT02732665 Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02732665 Recruiting Chalmers University of Technology 2019-03-31
NCT02732652 Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02732652 Recruiting Chalmers University of Technology 2019-03-31
NCT02730611 Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02730611 Completed Assistance Publique - Hôpitaux de Paris 2017-10-31
NCT02724345 Postoperative Adjuvant TACE Treatment in CK18 Positive Patients https://ClinicalTrials.gov/show/NCT02724345 Completed Eastern Hepatobiliary Surgery Hospital 2015-06-30
NCT02700659 The Cxbladder Monitoring Study https://ClinicalTrials.gov/show/NCT02700659 Completed Pacific Edge Limited 2016-09-23
NCT02674009 Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC) https://ClinicalTrials.gov/show/NCT02674009 Completed Hoffmann-La Roche 2019-03-31
NCT02670122 Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC https://ClinicalTrials.gov/show/NCT02670122 Completed Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 2018-11-30
NCT02672254 New Strategies Against Cutaneous Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT02672254 Completed Corporacion Parc Tauli 2016-01-31
NCT02664883 Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer https://ClinicalTrials.gov/show/NCT02664883 Recruiting University of Southern California 2020-09-08
NCT02663583 Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell https://ClinicalTrials.gov/show/NCT02663583 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT02649569 Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02649569 Completed Albert Einstein College of Medicine 2017-07-31
NCT02643173 Hepatocellular Carcinoma Recurrence and Anesthesia https://ClinicalTrials.gov/show/NCT02643173 Completed Seoul National University Bundang Hospital 2019-06-30
NCT02628379 Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary https://ClinicalTrials.gov/show/NCT02628379 Completed Foundation Medicine 2017-03-31
NCT02613156 Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02613156 Completed Sun Yat-sen University 2015-10-31
NCT02607605 A Prospective, Observational Trial on the Diagnostic and Prognostic of LM https://ClinicalTrials.gov/show/NCT02607605 Recruiting Sun Yat-sen University 2019-12-31
NCT02604472 Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT02604472 Completed Sun Yat-sen University 2013-06-30
NCT02597426 Nasopharyngeal Carcinoma Post IMRT https://ClinicalTrials.gov/show/NCT02597426 Active, not recruiting University Health Network, Toronto 2020-09-30
NCT02575547 Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients https://ClinicalTrials.gov/show/NCT02575547 Active, not recruiting Sun Yat-sen University 2016-09-30
NCT03148665 Saliva-based Detection of CD44 https://ClinicalTrials.gov/show/NCT03148665 Active, not recruiting University of California, San Diego 2019-04-10
NCT04353765 Non - Interventional, Retrospective Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors https://ClinicalTrials.gov/show/NCT04353765 Recruiting Ipsen 2020-12-30
NCT00046189 Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum https://ClinicalTrials.gov/show/NCT00046189 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03398980 Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy https://ClinicalTrials.gov/show/NCT03398980 Completed Sun Yat-sen University 2017-01-10
NCT02552745 Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization https://ClinicalTrials.gov/show/NCT02552745 Completed Sun Yat-sen University 2015-03-31
NCT02541149 Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02541149 Completed Ain Shams University 2015-06-30
NCT02543476 SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) https://ClinicalTrials.gov/show/NCT02543476 Completed AstraZeneca 2016-11-14
NCT02537743 Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02537743 Active, not recruiting iOMEDICO AG 2020-12-31
NCT02535026 An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants https://ClinicalTrials.gov/show/NCT02535026 Completed Hoffmann-La Roche 2013-12-31
NCT02506816 Preoperative Olaparib Endometrial Carcinoma Study (POLEN) https://ClinicalTrials.gov/show/NCT02506816 Completed MedSIR 2018-07-31
NCT02501993 Nasopharyngeal Carcinoma Screening in Zhongshan City https://ClinicalTrials.gov/show/NCT02501993 Recruiting Zhongshan People’s Hospital, Guangdong, China 2022-03-31
NCT02410603 Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer https://ClinicalTrials.gov/show/NCT02410603 Recruiting Mayo Clinic 2020-06-30
NCT02412579 Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation https://ClinicalTrials.gov/show/NCT02412579 Active, not recruiting Baylor Research Institute 2020-05-15
NCT02370303 A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System https://ClinicalTrials.gov/show/NCT02370303 Completed Mayo Clinic 2016-07-09
NCT02370277 Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer https://ClinicalTrials.gov/show/NCT02370277 Completed University of Southern California 2016-06-15
NCT02365844 Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT02365844 Completed Stanford University 2018-08-27
NCT02366286 Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants https://ClinicalTrials.gov/show/NCT02366286 Active, not recruiting Mayo Clinic 2022-12-31
NCT02364024 Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas https://ClinicalTrials.gov/show/NCT02364024 Completed Federation Francophone de Cancerologie Digestive 2009-05-31
NCT02358070 Epidemiologic Study of Hepatocellular Carcinoma in the US https://ClinicalTrials.gov/show/NCT02358070 Completed Stanford University 2016-09-01
NCT02355262 CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers https://ClinicalTrials.gov/show/NCT02355262 Active, not recruiting OHSU Knight Cancer Institute 2020-06-30
NCT02315755 Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC https://ClinicalTrials.gov/show/NCT02315755 Completed Pfizer 2017-11-20
NCT02302118 Esophagogastrectomy Versus Extended Gastrectomy in AEG II https://ClinicalTrials.gov/show/NCT02302118 Completed Universitätsklinikum Hamburg-Eppendorf 2015-10-31
NCT02296970 An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence https://ClinicalTrials.gov/show/NCT02296970 Completed University of Pittsburgh 2016-06-30
NCT02288910 Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver https://ClinicalTrials.gov/show/NCT02288910 Active, not recruiting Rush University Medical Center 2019-07-31
NCT02282579 Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy https://ClinicalTrials.gov/show/NCT02282579 Completed Spanish Oncology Genito-Urinary Group 2015-02-28
NCT02279459 Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas https://ClinicalTrials.gov/show/NCT02279459 Completed Ottawa Hospital Research Institute 2018-10-01
NCT02269995 Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02269995 Completed Eisai Inc. 2015-05-14
NCT02245100 Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02245100 Recruiting Thomas Jefferson University 2020-07-31
NCT02247583 Investigating Patient Satisfaction With Oral Anti-Cancer Treatment https://ClinicalTrials.gov/show/NCT02247583 Completed KU Leuven 2013-07-31
NCT02228954 IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) https://ClinicalTrials.gov/show/NCT02228954 Active, not recruiting Radboud University 2018-03-05
NCT02228265 Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide https://ClinicalTrials.gov/show/NCT02228265 Active, not recruiting OHSU Knight Cancer Institute 2019-10-01
NCT02199132 Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli https://ClinicalTrials.gov/show/NCT02199132 Completed Corporacion Parc Tauli 2014-10-31
NCT02187042 Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line https://ClinicalTrials.gov/show/NCT02187042 Completed Pfizer 2018-07-25
NCT02184416 Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting https://ClinicalTrials.gov/show/NCT02184416 Recruiting Pfizer 2021-05-01
NCT02185560 Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib https://ClinicalTrials.gov/show/NCT02185560 Active, not recruiting Bayer 2020-02-27
NCT04021056 Observational Study on Patients With Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT04021056 Recruiting Nanfang Hospital of Southern Medical University 2019-08-31
NCT02159339 DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma https://ClinicalTrials.gov/show/NCT02159339 Completed Beijing Cancer Hospital 2015-06-30
NCT02143492 Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC https://ClinicalTrials.gov/show/NCT02143492 Completed Argos Therapeutics 2015-07-31
NCT02139020 Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients https://ClinicalTrials.gov/show/NCT02139020 Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2023-01-31
NCT02128334 An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation https://ClinicalTrials.gov/show/NCT02128334 Completed Astellas Pharma Inc 2016-03-31
NCT02115477 Lymphedema After Primary Surgery for Endometrial Cancer https://ClinicalTrials.gov/show/NCT02115477 Completed University Hospital, Linkoeping 2018-12-17
NCT02113865 Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients https://ClinicalTrials.gov/show/NCT02113865 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2014-10-31
NCT02100111 An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants https://ClinicalTrials.gov/show/NCT02100111 Completed Hoffmann-La Roche 2011-12-31
NCT02095912 Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT02095912 Completed University of Zurich 2015-11-30
NCT02093104 TACE Study-Liver Embolization Perfusion (VGH Radiology LIU) https://ClinicalTrials.gov/show/NCT02093104 Completed University of British Columbia 2016-04-30
NCT01365208 New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT01365208 Completed Chinese University of Hong Kong 2017-03-03
NCT02063399 Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis https://ClinicalTrials.gov/show/NCT02063399 Active, not recruiting Chinese University of Hong Kong 2016-08-31
NCT02061956 A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02061956 Completed Sun Yat-sen University 2011-12-31
NCT01316679 An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 https://ClinicalTrials.gov/show/NCT01316679 Completed Vanderbilt University Medical Center 2013-01-31
NCT01304173 Retrospective Chart Review of Valstar https://ClinicalTrials.gov/show/NCT01304173 Completed Endo Pharmaceuticals 2011-09-30
NCT01295489 Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer https://ClinicalTrials.gov/show/NCT01295489 Completed Gynecologic Oncology Group 2018-01-31
NCT01279408 Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC) https://ClinicalTrials.gov/show/NCT01279408 Active, not recruiting University Health Network, Toronto 2028-11-30
NCT02056041 Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02056041 Completed University of Milan 2013-12-31
NCT02016833 Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity https://ClinicalTrials.gov/show/NCT02016833 Completed PX Biosolutions 2014-06-30
NCT02015026 Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma https://ClinicalTrials.gov/show/NCT02015026 Completed National Institutes of Health Clinical Center (CC) 2015-10-16
NCT01992861 MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer https://ClinicalTrials.gov/show/NCT01992861 Recruiting University of Washington 2021-09-30
NCT01957852 FloSeal in CRS and HIPEC https://ClinicalTrials.gov/show/NCT01957852 Completed Maisonneuve-Rosemont Hospital 2013-03-31
NCT01958515 Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation https://ClinicalTrials.gov/show/NCT01958515 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2017-02-15
NCT01953640 Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy https://ClinicalTrials.gov/show/NCT01953640 Active, not recruiting Mayo Clinic 2015-12-03
NCT01942005 EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients https://ClinicalTrials.gov/show/NCT01942005 Completed University Hospital, Basel, Switzerland 2014-05-31
NCT01933945 Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib https://ClinicalTrials.gov/show/NCT01933945 Completed Bayer 2017-07-22
NCT01917214 A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival https://ClinicalTrials.gov/show/NCT01917214 Completed Pfizer 2014-03-31
NCT01908322 Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety https://ClinicalTrials.gov/show/NCT01908322 Completed Bayer 2015-06-30
NCT01904942 Study of Hepatocellular Carcinoma in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01904942 Completed Centre Hospitalier Universitaire Dijon 2010-06-30
NCT01872130 Reflectance Confocal Microscopy of Wounds During Moh’s Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins https://ClinicalTrials.gov/show/NCT01872130 Completed Memorial Sloan Kettering Cancer Center 2020-04-28
NCT01839630 Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China https://ClinicalTrials.gov/show/NCT01839630 Completed Bayer 2016-08-06
NCT01840280 A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer https://ClinicalTrials.gov/show/NCT01840280 Completed Onkovis GmbH 2018-04-30
NCT01836484 Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma https://ClinicalTrials.gov/show/NCT01836484 Completed Barts & The London NHS Trust 2018-12-31
NCT01783158 Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma https://ClinicalTrials.gov/show/NCT01783158 Completed University Hospital Ostrava 2012-11-30
NCT01777698 Body Composition Analysis in Patients Undergoing Chemoembolization https://ClinicalTrials.gov/show/NCT01777698 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2015-08-31
NCT01759355 Hybrid PET/MR in the Therapy of Cervical Cancer https://ClinicalTrials.gov/show/NCT01759355 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2020-11-30
NCT01728948 Sorafenib in Elderly mRCC https://ClinicalTrials.gov/show/NCT01728948 Completed Bayer 2016-01-04
NCT01668108 A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer https://ClinicalTrials.gov/show/NCT01668108 Completed Onkovis GmbH 2018-05-31
NCT01657695 Hepatocellular Carcinoma Growth and Molecular Aggressiveness https://ClinicalTrials.gov/show/NCT01657695 Completed University of Modena and Reggio Emilia 2012-05-31
NCT01649778 Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01649778 Completed Novartis 2017-07-03
NCT01617382 Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed https://ClinicalTrials.gov/show/NCT01617382 Recruiting Universitaire Ziekenhuizen Leuven 2025-01-31
NCT01614002 A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer https://ClinicalTrials.gov/show/NCT01614002 Completed Onkovis GmbH 2015-03-31
NCT01606293 Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix https://ClinicalTrials.gov/show/NCT01606293 Recruiting M.D. Anderson Cancer Center 2021-05-31
NCT01585974 Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01585974 Completed Bayer 2015-06-30
NCT01545063 CAre of Patients With PArenteral Nutrition At Home https://ClinicalTrials.gov/show/NCT01545063 Completed KU Leuven 2013-04-30
NCT01540695 Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology https://ClinicalTrials.gov/show/NCT01540695 Completed Abramson Cancer Center of the University of Pennsylvania 2013-01-31
NCT01538498 Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer https://ClinicalTrials.gov/show/NCT01538498 Completed National Cancer Center, Korea 2012-11-30
NCT01539681 Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy https://ClinicalTrials.gov/show/NCT01539681 Completed Bayer 2014-01-31
NCT01520779 Recurrence of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01520779 Completed Ain Shams University 2012-11-30
NCT01518829 Procalcitonin in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01518829 Completed Ain Shams University 2012-12-31
NCT01508364 Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01508364 Completed Bayer 2013-12-31
NCT01500954 Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT01500954 Completed Ruhr University of Bochum 2011-12-31
NCT01498250 Microarray Analysis of microRNA Expression in Basal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01498250 Completed Ruhr University of Bochum 2011-12-31
NCT01487057 Lipid Metabolic Status in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01487057 Completed Prof. Dr. I. Chiricuta Institute of Oncology 2012-02-29
NCT01482520 Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01482520 Completed Samsung Medical Center 2013-09-30
NCT01481805 Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients https://ClinicalTrials.gov/show/NCT01481805 Completed Samsung Medical Center 2014-01-13
NCT01472419 Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT01472419 Completed Samsung Medical Center 2012-12-31
NCT01473121 Hepatocellular Carcinoma Registry for Turkey (3K Trial) https://ClinicalTrials.gov/show/NCT01473121 Completed Bayer 2017-06-30
NCT01446666 Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients https://ClinicalTrials.gov/show/NCT01446666 Completed Asan Medical Center 2014-12-31
NCT01441661 Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01441661 Completed Cancer Foundation, China 2012-06-30
NCT01434355 DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings https://ClinicalTrials.gov/show/NCT01434355 Completed Children’s Oncology Group 2016-08-04
NCT01424878 Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients https://ClinicalTrials.gov/show/NCT01424878 Completed National Institutes of Health Clinical Center (CC) NA
NCT01412671 Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program https://ClinicalTrials.gov/show/NCT01412671 Completed Bayer 2011-09-21
NCT01411436 Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan https://ClinicalTrials.gov/show/NCT01411436 Completed Bayer 2014-03-31
NCT01411423 Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan https://ClinicalTrials.gov/show/NCT01411423 Completed Bayer 2012-03-16
NCT01405183 Association Between Hepatitis C Infection and Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01405183 Completed Henry Ford Health System 2013-08-31
NCT01403480 Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions https://ClinicalTrials.gov/show/NCT01403480 Completed Rambam Health Care Campus 2010-12-31
NCT01395225 Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer https://ClinicalTrials.gov/show/NCT01395225 Completed University of British Columbia 2013-04-30
NCT01398306 Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. https://ClinicalTrials.gov/show/NCT01398306 Completed University Medical Center Groningen 2012-04-30
NCT01385722 Molecular Analysis of Thoracic Malignancies https://ClinicalTrials.gov/show/NCT01385722 Enrolling by invitation Stanford University 2031-06-30
NCT01381614 Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS) https://ClinicalTrials.gov/show/NCT01381614 Completed GlaxoSmithKline 2011-12-31
NCT01381601 Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics) https://ClinicalTrials.gov/show/NCT01381601 Completed GlaxoSmithKline 2011-10-31
NCT01372787 Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer https://ClinicalTrials.gov/show/NCT01372787 Active, not recruiting Gynecologic Oncology Group 2014-01-31
NCT01370824 Clinical Diagnosis of Basal Cell Carcinoma Subtype https://ClinicalTrials.gov/show/NCT01370824 Completed Maastricht University Medical Center 2013-02-28
NCT01367457 INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus https://ClinicalTrials.gov/show/NCT01367457 Completed Pfizer 2015-04-30
NCT01361061 AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver https://ClinicalTrials.gov/show/NCT01361061 Completed University Hospital Freiburg 2015-11-30
NCT01360255 AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) https://ClinicalTrials.gov/show/NCT01360255 Completed University Hospital Freiburg 2015-11-30
NCT01358097 Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy https://ClinicalTrials.gov/show/NCT01358097 Completed Icahn School of Medicine at Mount Sinai 2013-09-30
NCT01349075 TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01349075 Recruiting Thomas Jefferson University 2020-12-31
NCT01339975 Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01339975 Completed University Hospital, Bordeaux 2014-05-31
NCT01339962 Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2. https://ClinicalTrials.gov/show/NCT01339962 Completed Pfizer 2012-04-30
NCT01321892 Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium https://ClinicalTrials.gov/show/NCT01321892 Completed Icahn School of Medicine at Mount Sinai 2012-05-31
NCT03233360 Hepatocellular Carcinoma Registry in Asia https://ClinicalTrials.gov/show/NCT03233360 Recruiting National Cancer Centre, Singapore 2022-03-31
NCT04416646 Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT04416646 Recruiting Istituto Oncologico Veneto IRCCS 2020-06-27
NCT04410302 Patient-Derived Xenografts to Reduce Cancer Health Disparities https://ClinicalTrials.gov/show/NCT04410302 Recruiting University of California, Davis 2023-06-30
NCT04375150 Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC https://ClinicalTrials.gov/show/NCT04375150 Active, not recruiting Pfizer 2021-03-02
NCT04367805 COVID-19 Infection in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04367805 Recruiting Centre Hospitalier Universitaire, Amiens 2020-10-31
NCT04350047 Renal Cell Carcinoma and Stage IV Inferior Vena Cava Thrombus: Resection Without Thoracotomy https://ClinicalTrials.gov/show/NCT04350047 Completed Attikon Hospital 2020-03-31
NCT04348838 Prospective Cohort of Patients With Hepatocellular Carcinoma in France https://ClinicalTrials.gov/show/NCT04348838 Recruiting Centre Hospitalier Universitaire, Amiens 2027-09-30
NCT04341337 Link of Interest and Training Model https://ClinicalTrials.gov/show/NCT04341337 Completed Centre de l’arthrose, Paris 2020-04-06
NCT04314245 Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT04314245 Recruiting AnchorDx Medical Co., Ltd. 2020-08-31
NCT04307654 Lactate and Complications in Cytoreduction Surgery for Peritoneal Carcinomatosis https://ClinicalTrials.gov/show/NCT04307654 Completed Hospital General Universitario de Castellón 2014-06-30
NCT04309617 Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy https://ClinicalTrials.gov/show/NCT04309617 Recruiting Pfizer 2020-04-15
NCT04303286 The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04303286 Recruiting Tongji Hospital 2020-05-31
NCT04299919 The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment https://ClinicalTrials.gov/show/NCT04299919 Active, not recruiting The First Affiliated Hospital of Dalian Medical University 2023-06-30
NCT04296058 The Mechanism of Sox4 Transcription in Regulation of Angiogenesis in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04296058 Completed Chang Gung Memorial Hospital 2019-03-31
NCT04264754 Characterization of Methylation Patterns in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04264754 Recruiting Nucleix Ltd. 2024-12-31
NCT04257045 Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives https://ClinicalTrials.gov/show/NCT04257045 Recruiting M.D. Anderson Cancer Center 2022-12-31
NCT04252560 The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer. https://ClinicalTrials.gov/show/NCT04252560 Recruiting Uppsala University Hospital 2021-01-31
NCT04260074 Epigenetic Changes in Head and Neck Cancer https://ClinicalTrials.gov/show/NCT04260074 Recruiting Aalborg University Hospital 2020-07-31
NCT04239781 A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04239781 Recruiting Shanghai Zhongshan Hospital 2020-06-30
NCT04228237 LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS) https://ClinicalTrials.gov/show/NCT04228237 Recruiting Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s. 2025-05-31
NCT04224389 IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas https://ClinicalTrials.gov/show/NCT04224389 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2023-06-30
NCT04222374 Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC) https://ClinicalTrials.gov/show/NCT04222374 Recruiting University Hospital, Bordeaux 2020-04-30
NCT04221347 Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC https://ClinicalTrials.gov/show/NCT04221347 Recruiting Military University Hospital, Prague 2020-12-31
NCT04213664 Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma. https://ClinicalTrials.gov/show/NCT04213664 Recruiting Corporacion Parc Tauli 2020-01-02
NCT04209491 Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway https://ClinicalTrials.gov/show/NCT04209491 Recruiting Assistance Publique - Hôpitaux de Paris 2020-02-01
NCT04204811 Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy https://ClinicalTrials.gov/show/NCT04204811 Recruiting Memorial Sloan Kettering Cancer Center 2020-12-16
NCT04201002 Surgery Plus Intraoperative Radiotherapy as Treatment for Squamous Cell Carcinoma Over Pilonidal Disease. https://ClinicalTrials.gov/show/NCT04201002 Completed Hospital Provincial de Castellon 2019-10-11
NCT04199832 To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy https://ClinicalTrials.gov/show/NCT04199832 Recruiting Tianjin Medical University Cancer Institute and Hospital 2020-12-31
NCT04189809 Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations https://ClinicalTrials.gov/show/NCT04189809 Active, not recruiting University Hospital, Montpellier 2020-03-01
NCT04183218 Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes in Non-metastatic, Non-recurrent Lung and Esophageal Cancer Patients https://ClinicalTrials.gov/show/NCT04183218 Recruiting Mayo Clinic 2021-09-23
NCT04177316 Hypermethylation of VTRNA2-1 Promoter in HCC Outcome https://ClinicalTrials.gov/show/NCT04177316 Completed Chang Gung Memorial Hospital 2019-11-15
NCT04175262 Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments https://ClinicalTrials.gov/show/NCT04175262 Completed Pfizer 2020-03-09
NCT04172194 Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas https://ClinicalTrials.gov/show/NCT04172194 Completed Centre Hospitalier Universitaire de Nice 2014-12-31
NCT04161911 A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy https://ClinicalTrials.gov/show/NCT04161911 Completed Bristol-Myers Squibb 2018-11-15
NCT04161287 Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE https://ClinicalTrials.gov/show/NCT04161287 Recruiting Beijing 302 Hospital 2022-11-11
NCT04160897 Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT04160897 Enrolling by invitation Ruijin Hospital 2020-10-31
NCT04152356 Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04152356 Recruiting Guangxi Medical University 2020-08-01
NCT04151940 PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04151940 Recruiting University of Washington 2021-06-01
NCT04147143 CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study https://ClinicalTrials.gov/show/NCT04147143 Recruiting Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 2020-03-08
NCT04115189 A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA) https://ClinicalTrials.gov/show/NCT04115189 Recruiting Pfizer 2020-04-30
NCT04108936 Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses https://ClinicalTrials.gov/show/NCT04108936 Recruiting University of Regensburg 2020-06-30
NCT04106167 Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy https://ClinicalTrials.gov/show/NCT04106167 Recruiting Fate Therapeutics 2034-02-28
NCT04094545 Intestinal Flora Sequencing for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04094545 Completed The Third Xiangya Hospital of Central South University 2018-12-31
NCT04099290 Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT04099290 Recruiting UNC Lineberger Comprehensive Cancer Center 2020-09-30
NCT04076787 Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib https://ClinicalTrials.gov/show/NCT04076787 Completed Pfizer 2018-09-02
NCT04076631 Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04076631 Recruiting Tongji Hospital 2020-09-30
NCT04069299 Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract https://ClinicalTrials.gov/show/NCT04069299 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-12-01
NCT04066504 Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma https://ClinicalTrials.gov/show/NCT04066504 Recruiting Sun Pharmaceutical Industries Limited 2024-11-01
NCT04053855 Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT04053855 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2021-09-30
NCT04050761 A Study of Nivolumab in Patients With Head and Neck Cancer. https://ClinicalTrials.gov/show/NCT04050761 Recruiting Bristol-Myers Squibb 2024-06-26
NCT04033991 Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. https://ClinicalTrials.gov/show/NCT04033991 Active, not recruiting Pfizer 2020-05-31
NCT04043975 A Prospective Observational Study of Renal Cell Cancer Patients Treated With Nivolumab Plus Ipilimumab in the Real World Setting in Japan https://ClinicalTrials.gov/show/NCT04043975 Recruiting Bristol-Myers Squibb 2022-08-01
NCT04027543 Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study) https://ClinicalTrials.gov/show/NCT04027543 Completed Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 2019-12-01
NCT04021069 Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer https://ClinicalTrials.gov/show/NCT04021069 Active, not recruiting Sunnybrook Health Sciences Centre 2019-12-30
NCT04008082 A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04008082 Recruiting Eisai Inc. 2023-05-31
NCT04005183 Renal Cell Carcinoma Microenvironment Discovery Project https://ClinicalTrials.gov/show/NCT04005183 Recruiting University Health Network, Toronto 2030-05-01
NCT04006405 AURORAX-087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC https://ClinicalTrials.gov/show/NCT04006405 Recruiting Elypta 2022-02-28
NCT04003025 Body Composition and Prognosis in Head and Neck Squamous Cell Carcinoma (HNSCC) https://ClinicalTrials.gov/show/NCT04003025 Recruiting Instituto do Cancer do Estado de São Paulo 2020-07-31
NCT03998371 Application of UCAD for Diagnosing Urothelial Carcinoma. https://ClinicalTrials.gov/show/NCT03998371 Recruiting Changhai Hospital 2020-05-05
NCT03989297 PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03989297 Recruiting Kiang Wu Hospital 2019-12-01
NCT03987555 Paclitaxel Therapeutic Drug Monitoring in Cancer Patients https://ClinicalTrials.gov/show/NCT03987555 Recruiting Wake Forest University Health Sciences 2021-03-31
NCT03981224 The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03981224 Completed Taichung Veterans General Hospital 2013-05-01
NCT03958669 Fingerprint Characterization of Sorafenib Treated HCC https://ClinicalTrials.gov/show/NCT03958669 Recruiting University Hospital Tuebingen 2021-06-30
NCT03953443 Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC https://ClinicalTrials.gov/show/NCT03953443 Enrolling by invitation New Mexico Cancer Care Alliance 2025-12-31
NCT03945786 Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03945786 Enrolling by invitation Xuanwu Hospital, Beijing 2020-12-31
NCT03938012 Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03938012 Recruiting National University Hospital, Singapore 2021-10-31
NCT03928964 MEtatastic Renal Carcinoma LINes https://ClinicalTrials.gov/show/NCT03928964 Active, not recruiting Centre Hospitalier Universitaire de Besancon 2018-10-03
NCT03931304 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) https://ClinicalTrials.gov/show/NCT03931304 Completed Hospices Civils de Lyon 2018-07-31
NCT03916458 REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA https://ClinicalTrials.gov/show/NCT03916458 Recruiting Pfizer 2020-09-30
NCT03904667 Application of Watson for Oncology in Hepatocellular Carcinoma Surgery https://ClinicalTrials.gov/show/NCT03904667 Active, not recruiting Zhujiang Hospital 2021-12-31
NCT03902535 Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers https://ClinicalTrials.gov/show/NCT03902535 Recruiting City of Hope Medical Center 2020-12-10
NCT03894917 Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03894917 Recruiting The University of Texas Health Science Center at San Antonio 2020-04-30
NCT03881501 Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03881501 Recruiting Huazhong University of Science and Technology 2020-03-31
NCT03880721 By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation https://ClinicalTrials.gov/show/NCT03880721 Recruiting Chinese PLA General Hospital 2020-08-31
NCT03878550 Case-Control Study of the Glycotestâ„¢ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03878550 Recruiting Glycotest, Inc. 2020-12-31
NCT03855020 Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03855020 Recruiting Sun Yat-sen University 2022-05-10
NCT03852238 Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) https://ClinicalTrials.gov/show/NCT03852238 Completed University Hospital, Bordeaux 2013-11-14
NCT03830996 Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03830996 Recruiting The University of Hong Kong 2020-12-31
NCT03810274 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03810274 Completed Xinqiao Hospital of Chongqing 2018-12-31
NCT03805971 Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis. https://ClinicalTrials.gov/show/NCT03805971 Completed University of Liege 2019-10-15
NCT03804593 HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03804593 Completed Epigenomics, Inc 2019-10-01
NCT03804255 Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting https://ClinicalTrials.gov/show/NCT03804255 Recruiting Eastern Cooperative Oncology Group 2020-02-01
NCT03798132 Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic. https://ClinicalTrials.gov/show/NCT03798132 Recruiting South Egypt Cancer Institute 2019-06-11
NCT03794115 Immune Repertoire of Ovarian HGSC https://ClinicalTrials.gov/show/NCT03794115 Recruiting Peking Union Medical College Hospital 2021-01-01
NCT03776123 Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYXâ„¢ in Korea. https://ClinicalTrials.gov/show/NCT03776123 Recruiting Ipsen 2022-02-28
NCT03775863 AFP Model and Liver Transplantation. https://ClinicalTrials.gov/show/NCT03775863 Completed Austral University, Argentina 2018-12-12
NCT03774862 Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT03774862 Completed V.K.V. American Hospital, Istanbul 2017-12-31
NCT03767764 Yliver as a Test to Early Diagnose HCC https://ClinicalTrials.gov/show/NCT03767764 Active, not recruiting Corporacion Parc Tauli 2020-04-01
NCT03766672 Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique https://ClinicalTrials.gov/show/NCT03766672 Recruiting University Hospital Center of Martinique 2021-01-07
NCT03759730 Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03759730 Completed University Health Network, Toronto 2018-11-28
NCT03756051 Harms of Hepatocellular Carcinoma Surveillance https://ClinicalTrials.gov/show/NCT03756051 Active, not recruiting University of Texas Southwestern Medical Center 2022-04-30
NCT03748901 PD-L1 Expression in Japanese Renal Cell Carcinoma Patients https://ClinicalTrials.gov/show/NCT03748901 Active, not recruiting Chugai Pharmaceutical 2019-12-31
NCT03744585 Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts. https://ClinicalTrials.gov/show/NCT03744585 Completed Ipsen 2019-06-07
NCT03737695 Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer https://ClinicalTrials.gov/show/NCT03737695 Recruiting Mayo Clinic 2020-11-05
NCT03734614 Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03734614 Recruiting RenJi Hospital 2024-10-31
NCT03735511 A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma https://ClinicalTrials.gov/show/NCT03735511 Active, not recruiting Henan Cancer Hospital 2020-08-31
NCT03734068 Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC https://ClinicalTrials.gov/show/NCT03734068 Recruiting International Group of Endovascular Oncology 2021-06-30
NCT03728842 Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03728842 Recruiting Indiana University 2021-03-01
NCT03727594 Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03727594 Recruiting University Hospital of Ferrara 2020-01-31
NCT03712566 Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy https://ClinicalTrials.gov/show/NCT03712566 Active, not recruiting University Health Network, Toronto 2022-10-31
NCT03707080 Direct Acting Antiviral-Post Authorization Safety Study https://ClinicalTrials.gov/show/NCT03707080 Active, not recruiting Target PharmaSolutions, Inc. 2020-12-31
NCT03699579 Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC https://ClinicalTrials.gov/show/NCT03699579 Completed Ipsen 2019-06-23
NCT03702998 Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population https://ClinicalTrials.gov/show/NCT03702998 Recruiting Chinese University of Hong Kong 2020-07-31
NCT03696407 A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK https://ClinicalTrials.gov/show/NCT03696407 Completed Ipsen 2019-08-01
NCT03670992 Surgical Treatment of Pancreatic RCC Metastases https://ClinicalTrials.gov/show/NCT03670992 Completed Azienda Policlinico Umberto I 2017-01-10
NCT03663946 A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread https://ClinicalTrials.gov/show/NCT03663946 Recruiting Bristol-Myers Squibb 2021-12-31
NCT03663114 A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03663114 Active, not recruiting Eisai Inc. 2021-05-31
NCT03647878 Study of Cabozantinib in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment. https://ClinicalTrials.gov/show/NCT03647878 Recruiting Ipsen 2022-08-30
NCT03647527 Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy https://ClinicalTrials.gov/show/NCT03647527 Recruiting Zhejiang Cancer Hospital 2018-11-30
NCT03630068 Computer-assisted Tumor Ablation for Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT03630068 Completed University Hospital Inselspital, Berne 2017-12-31
NCT03628651 Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03628651 Completed Exact Sciences Corporation 2020-03-11
NCT03612726 The Overall Survival of Patients With Unresectable HCC in Real-life https://ClinicalTrials.gov/show/NCT03612726 Recruiting Humanity & Health Medical Group Limited 2023-07-31
NCT03604601 Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal Carcinoma https://ClinicalTrials.gov/show/NCT03604601 Completed First Affiliated Hospital, Sun Yat-Sen University 2018-06-01
NCT03601390 Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC https://ClinicalTrials.gov/show/NCT03601390 Recruiting Sun Yat-sen University 2019-12-01
NCT03593681 Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy https://ClinicalTrials.gov/show/NCT03593681 Completed Boston Scientific Corporation 2020-02-14
NCT03588442 Prospective Surveillance for Very Early Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03588442 Recruiting Eastern Hepatobiliary Surgery Hospital 2022-07-15
NCT03588403 TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03588403 Recruiting Zhejiang Cancer Hospital 2022-07-31
NCT03583528 DOTATOC PET/CT for Imaging NET Patients https://ClinicalTrials.gov/show/NCT03583528 Recruiting British Columbia Cancer Agency 2023-12-31
NCT03581435 A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients https://ClinicalTrials.gov/show/NCT03581435 Recruiting Shanghai Jiao Tong University School of Medicine 2018-12-30
NCT03563352 Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer https://ClinicalTrials.gov/show/NCT03563352 Recruiting University of Southern California 2020-08-30
NCT03554967 Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03554967 Completed Cairo University 2019-06-03
NCT03534843 A Comparison Between Child-Pugh and Albumin-Bilirubin Scores https://ClinicalTrials.gov/show/NCT03534843 Completed Huazhong University of Science and Technology 2015-08-01
NCT03529604 Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients https://ClinicalTrials.gov/show/NCT03529604 Active, not recruiting University of Zagreb 2020-04-01
NCT03519542 Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03519542 Completed Spanish Oncology Genito-Urinary Group 2016-12-31
NCT03516890 Management of Spontaneous Ruptured Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03516890 Completed Huazhong University of Science and Technology 2015-06-01
NCT03509415 Reflectance Confocal Microscopy to Diagnose BCC https://ClinicalTrials.gov/show/NCT03509415 Active, not recruiting Skin Care Network Ltd. 2019-02-28
NCT03490461 Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation https://ClinicalTrials.gov/show/NCT03490461 Completed Yonsei University 2018-03-01
NCT03483922 HCC Screening Using DNA Methylation Changes in ctDNA https://ClinicalTrials.gov/show/NCT03483922 Recruiting HKGepitherapeutics 2020-06-01
NCT03476421 R1vascular Hepatectomy for HCC Patients https://ClinicalTrials.gov/show/NCT03476421 Completed Humanitas Clinical and Research Center 2015-12-31
NCT03471897 Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03471897 Completed Chalmers University of Technology 2017-10-25
NCT03469596 Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor? https://ClinicalTrials.gov/show/NCT03469596 Completed Groupe Hospitalier Paris Saint Joseph 2017-05-01
NCT03455452 An Observational Study of Nivolumab in Participants With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT03455452 Recruiting Bristol-Myers Squibb 2022-01-18
NCT03430635 Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03430635 Completed Humanitas Clinical and Research Center 2015-12-31
NCT03419572 Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03419572 Recruiting Ipsen 2021-01-05
NCT03411954 Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03411954 Recruiting Zhejiang Cancer Hospital 2021-02-28
NCT01268878 Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol https://ClinicalTrials.gov/show/NCT01268878 Completed Groupe Oncologie Radiotherapie Tete et Cou 2011-11-30
NCT01237132 East-West Hepatocellular Carcinoma Study Group https://ClinicalTrials.gov/show/NCT01237132 Completed University of Milan NA
NCT01227213 The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01227213 Completed Radboud University 2013-11-30
NCT01212562 Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery https://ClinicalTrials.gov/show/NCT01212562 Completed University of Ioannina 2010-04-30
NCT01210313 Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma https://ClinicalTrials.gov/show/NCT01210313 Completed Austrian Breast & Colorectal Cancer Study Group 2013-04-30
NCT01179360 Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) https://ClinicalTrials.gov/show/NCT01179360 Completed University Hospital, Antwerp 2015-12-31
NCT01173445 Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01173445 Completed University of Kansas Medical Center 2011-05-31
NCT01151007 KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009 https://ClinicalTrials.gov/show/NCT01151007 Completed University Hospital Center of Martinique 2011-10-31
NCT01135849 B-Receptor Signaling in Cardiomyopathy https://ClinicalTrials.gov/show/NCT01135849 Completed Stanford University 2010-10-31
NCT01135823 Symptom Assessment With Patient Surveys https://ClinicalTrials.gov/show/NCT01135823 Completed Stanford University 2008-06-30
NCT01103544 JAVLOR® Online Non-Interventional Trial https://ClinicalTrials.gov/show/NCT01103544 Completed Pierre Fabre Pharma GmbH 2011-09-30
NCT01098630 Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer https://ClinicalTrials.gov/show/NCT01098630 Completed Gynecologic Oncology Group 2012-05-31
NCT01080521 Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT01080521 Completed Gynecologic Oncology Group 2012-01-31
NCT01080066 A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN) https://ClinicalTrials.gov/show/NCT01080066 Completed Merck KGaA, Darmstadt, Germany 2013-12-31
NCT01052740 X-Ray Mammography Standard of Care Protocol https://ClinicalTrials.gov/show/NCT01052740 Completed National Institutes of Health Clinical Center (CC) NA
NCT01050504 Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer https://ClinicalTrials.gov/show/NCT01050504 Recruiting University of Washington 2021-09-01
NCT01034865 Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT01034865 Completed Stanford University 2009-06-30
NCT01028638 Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01028638 Completed University Medical Center Groningen 2015-01-31
NCT01026337 Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT01026337 Completed Abramson Cancer Center of the University of Pennsylvania 2015-12-31
NCT01012011 Regulatory Post Marketing Surveillance Study on Nexavar® https://ClinicalTrials.gov/show/NCT01012011 Completed Bayer 2015-01-31
NCT00997633 Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy https://ClinicalTrials.gov/show/NCT00997633 Completed Uppsala University 2004-08-31
NCT00952874 Molecular Biology of Anal Cancer in HIV-Positive Patients https://ClinicalTrials.gov/show/NCT00952874 Completed University Hospital, Geneva 2010-01-31
NCT00930319 Effectiveness and Safety of Firmagon® https://ClinicalTrials.gov/show/NCT00930319 Completed Ferring Pharmaceuticals 2013-12-31
NCT00927043 Study Evaluating Renal Cell Carcinoma Risk Factors https://ClinicalTrials.gov/show/NCT00927043 Completed Pfizer 2011-09-30
NCT00918775 Follow-up After Metastasectomy in Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT00918775 Active, not recruiting M.D. Anderson Cancer Center 2020-12-20
NCT00911196 Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00911196 Completed GlaxoSmithKline 2009-03-31
NCT00897442 Collecting Tumor Samples From Patients With Gynecological Tumors https://ClinicalTrials.gov/show/NCT00897442 Completed Gynecologic Oncology Group 2016-01-31
NCT00901173 A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya https://ClinicalTrials.gov/show/NCT00901173 Completed National Institutes of Health Clinical Center (CC) 2020-04-20
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00895674 Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar https://ClinicalTrials.gov/show/NCT00895674 Completed Bayer 2010-08-31
NCT00890903 Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) https://ClinicalTrials.gov/show/NCT00890903 Completed Pierre Fabre Pharma GmbH 2012-04-30
NCT00883454 Estimation of Functional Liver Reserve Using Cholinesterases https://ClinicalTrials.gov/show/NCT00883454 Completed University of Milan NA
NCT00882791 Basal Cell Carcinoma Recurrence After Mohs Surgery https://ClinicalTrials.gov/show/NCT00882791 Completed Northwestern University 2009-05-31
NCT00880503 Collection of Tissue Samples for Study of Multidrug Resistance https://ClinicalTrials.gov/show/NCT00880503 Completed National Institutes of Health Clinical Center (CC) NA
NCT00858000 Analysis of Expression of Specific Markers in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00858000 Completed GlaxoSmithKline 2009-12-31
NCT03788746 Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT03788746 Recruiting AstraZeneca 2020-12-09
NCT03210935 French National Database of Rare Dermatological Cancers https://ClinicalTrials.gov/show/NCT03210935 Recruiting University Hospital, Lille 2025-12-31
NCT02156700 Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors https://ClinicalTrials.gov/show/NCT02156700 Completed University Hospital Dubrava 2015-12-31
NCT00831857 VEGF Imaging in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00831857 Completed University Medical Center Groningen 2011-09-30
NCT00829335 Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach https://ClinicalTrials.gov/show/NCT00829335 Completed University of Milan 2009-01-31
NCT04291755 Development and Analysis of a Stool Bank for Cancer Patients https://ClinicalTrials.gov/show/NCT04291755 Recruiting Persephone Biosciences 2020-12-31
NCT04412161 Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP https://ClinicalTrials.gov/show/NCT04412161 Completed Inonu University 2019-01-01
NCT03100708 Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy) https://ClinicalTrials.gov/show/NCT03100708 Recruiting University of Leipzig 2021-04-30
NCT03071458 Mutational Landscape in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03071458 Completed Institut National de la Santé Et de la Recherche Médicale, France 2015-05-31
NCT02834546 Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02834546 Completed University Hospital, Bordeaux 2019-03-15
NCT01942200 A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer https://ClinicalTrials.gov/show/NCT01942200 Completed Onkovis GmbH 2018-07-25
NCT01557127 Nexavar Dosing in Renal Cancer Patients in “Real-life” Setting https://ClinicalTrials.gov/show/NCT01557127 Completed Bayer 2014-05-16
NCT00804128 Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS) https://ClinicalTrials.gov/show/NCT00804128 Recruiting University of California, San Francisco 2024-12-31
NCT00876382 Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00876382 Completed SCRI Development Innovations, LLC 2011-02-28
NCT00875381 Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin https://ClinicalTrials.gov/show/NCT00875381 Completed Mayo Clinic 2007-12-31
NCT00873210 Study In Patients With Kidney Cancer Treated With Sutent https://ClinicalTrials.gov/show/NCT00873210 Completed Pfizer 2011-11-30
NCT00842790 Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging https://ClinicalTrials.gov/show/NCT00842790 Completed Assistance Publique - Hôpitaux de Paris 2014-07-31
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT00834028 Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization https://ClinicalTrials.gov/show/NCT00834028 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2008-12-31
NCT04415567 Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation https://ClinicalTrials.gov/show/NCT04415567 Completed Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2020-03-31
NCT04411290 Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases https://ClinicalTrials.gov/show/NCT04411290 Enrolling by invitation Umraniye Education and Research Hospital 2021-06-01
NCT03414827 Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03414827 Recruiting Zealand University Hospital 2020-12-01
NCT02476669 Serial Plasma EBV DNA for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02476669 Recruiting The University of Hong Kong 2020-12-31
NCT00812175 Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib https://ClinicalTrials.gov/show/NCT00812175 Completed Bayer 2012-04-30
NCT01982097 Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01982097 Completed Bayer 2017-01-31
NCT01976468 Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The “SCOPE-ITSCC Metastases Study” https://ClinicalTrials.gov/show/NCT01976468 Active, not recruiting University of Zurich 2023-01-31
NCT04163627 Changing Trends in HCC Procedures https://ClinicalTrials.gov/show/NCT04163627 Recruiting University Hospital, Montpellier 2021-03-01
NCT04430725 Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study https://ClinicalTrials.gov/show/NCT04430725 Recruiting M.D. Anderson Cancer Center 2023-01-01
NCT03267641 Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03267641 Recruiting National Cancer Centre, Singapore 2021-05-31
NCT03203837 Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® https://ClinicalTrials.gov/show/NCT03203837 Recruiting Northwestern University 2020-05-31
NCT03178409 Combined HCC-MFCCC https://ClinicalTrials.gov/show/NCT03178409 Completed University of Milan 2014-12-31
NCT03050268 Familial Investigations of Childhood Cancer Predisposition https://ClinicalTrials.gov/show/NCT03050268 Recruiting St. Jude Children’s Research Hospital 2037-03-31
NCT02773667 Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine https://ClinicalTrials.gov/show/NCT02773667 Recruiting Jena University Hospital 2020-12-31
NCT02549638 Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT02549638 Recruiting Mayo Clinic 2020-08-31
NCT02558205 Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry https://ClinicalTrials.gov/show/NCT02558205 Recruiting Rush University Medical Center 2020-07-31
NCT02371967 A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC) https://ClinicalTrials.gov/show/NCT02371967 Active, not recruiting Hoffmann-La Roche 2020-08-29
NCT04451603 LiverMultiScan Analysis of MRI Scans in HCC https://ClinicalTrials.gov/show/NCT04451603 Recruiting National Cancer Centre, Singapore 2021-12-31
NCT01650987 Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function https://ClinicalTrials.gov/show/NCT01650987 Completed Centre Oscar Lambret 2015-05-31
NCT01490203 Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01490203 Completed Seoul National University Hospital 2014-02-28
NCT04432909 A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up https://ClinicalTrials.gov/show/NCT04432909 Recruiting Changhai Hospital 2022-01-30
NCT01328691 Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus https://ClinicalTrials.gov/show/NCT01328691 Completed Seoul National University Hospital 2011-03-31
NCT03973723 Plasma EBV DNA Monitoring in Post-treatment NPC Patients https://ClinicalTrials.gov/show/NCT03973723 Completed Taichung Veterans General Hospital 2013-12-31
NCT00827723 Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma https://ClinicalTrials.gov/show/NCT00827723 Completed University of Lausanne Hospitals 2018-02-28
NCT01014065 A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) https://ClinicalTrials.gov/show/NCT01014065 Completed AHS Cancer Control Alberta 2012-11-30
NCT00792350 INSIGHT - Post Marketing Surveillance https://ClinicalTrials.gov/show/NCT00792350 Completed Bayer 2013-10-31
NCT00793169 Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery https://ClinicalTrials.gov/show/NCT00793169 Completed Northwestern University 2008-07-31
NCT00771147 A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ® https://ClinicalTrials.gov/show/NCT00771147 Completed Bayer NA
NCT00764140 Tumor Growth Factors in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00764140 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2010-04-30
NCT00759382 Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study. https://ClinicalTrials.gov/show/NCT00759382 Active, not recruiting European Lung Cancer Working Party 2021-01-31
NCT00743054 microRNA Expression in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00743054 Completed Sun Yat-sen University 2009-08-31
NCT00718367 Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens https://ClinicalTrials.gov/show/NCT00718367 Completed National University Hospital, Singapore NA
NCT00717743 T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY) https://ClinicalTrials.gov/show/NCT00717743 Completed National University Hospital, Singapore NA
NCT00700258 Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] https://ClinicalTrials.gov/show/NCT00700258 Recruiting Pfizer 2023-12-01
NCT00684645 Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT® https://ClinicalTrials.gov/show/NCT00684645 Completed Pfizer 2011-04-30
NCT00662662 Sexual Behavior in Head and Neck Cancer Patients https://ClinicalTrials.gov/show/NCT00662662 Active, not recruiting M.D. Anderson Cancer Center 2022-05-31
NCT00630240 Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization https://ClinicalTrials.gov/show/NCT00630240 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2009-02-28
NCT00629421 Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study https://ClinicalTrials.gov/show/NCT00629421 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2016-12-31
NCT00620139 Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT00620139 Completed Memorial Sloan Kettering Cancer Center 2013-10-31
NCT00605150 HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC https://ClinicalTrials.gov/show/NCT00605150 Completed Atrium Health 2012-07-31
NCT00601185 Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. https://ClinicalTrials.gov/show/NCT00601185 Completed Memorial Sloan Kettering Cancer Center 2018-02-23
NCT00581750 Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ https://ClinicalTrials.gov/show/NCT00581750 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-10-31
NCT00574392 Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo https://ClinicalTrials.gov/show/NCT00574392 Completed Memorial Sloan Kettering Cancer Center 2013-09-30
NCT00568139 Evaluation of Side Effects of Mitotane https://ClinicalTrials.gov/show/NCT00568139 Recruiting University of Wuerzburg 2020-12-31
NCT00540059 Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial https://ClinicalTrials.gov/show/NCT00540059 Completed AstraZeneca NA
NCT00513175 Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia https://ClinicalTrials.gov/show/NCT00513175 Completed University of California, San Francisco NA
NCT00488878 Data Collection for Patients With Low Grade Ovarian Carcinoma https://ClinicalTrials.gov/show/NCT00488878 Recruiting M.D. Anderson Cancer Center 2034-05-31
NCT00477100 Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer https://ClinicalTrials.gov/show/NCT00477100 Recruiting M.D. Anderson Cancer Center 2020-04-30
NCT00469066 Cone Beam CT Scanning in Lung and Bladder Cancer. https://ClinicalTrials.gov/show/NCT00469066 Completed AHS Cancer Control Alberta 2009-08-31
NCT00460798 SUTENT® In The First Line Treatment Of Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00460798 Completed Pfizer 2009-09-30
NCT00460356 Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes https://ClinicalTrials.gov/show/NCT00460356 Completed Gynecologic Oncology Group 2016-07-16
NCT00453674 German Adrenocortical Carcinoma Registry https://ClinicalTrials.gov/show/NCT00453674 Recruiting University of Wuerzburg 2023-12-31
NCT00439127 OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation https://ClinicalTrials.gov/show/NCT00439127 Completed Oncology Institute of Southern Switzerland NA
NCT00388024 PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy https://ClinicalTrials.gov/show/NCT00388024 Completed Wake Forest University Health Sciences 2008-12-31
NCT00923884 Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer https://ClinicalTrials.gov/show/NCT00923884 Completed National Institutes of Health Clinical Center (CC) NA
NCT00341146 Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) https://ClinicalTrials.gov/show/NCT00341146 Completed National Institutes of Health Clinical Center (CC) 2006-08-20
NCT00263731 Metabolomic Analysis of Lung Cancer https://ClinicalTrials.gov/show/NCT00263731 Recruiting University of Louisville 2025-12-31
NCT00218868 Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear https://ClinicalTrials.gov/show/NCT00218868 Completed Norwegian University of Science and Technology 2006-02-28
NCT00222404 Pharmacogenomic Study Realized on “Non-small Cell Lung Carcinoma” https://ClinicalTrials.gov/show/NCT00222404 Completed University Hospital, Grenoble NA
NCT00218829 DMSO-PDT of BCC - A 6 Year Follow up https://ClinicalTrials.gov/show/NCT00218829 Completed Norwegian University of Science and Technology 2004-12-31
NCT00195299 Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck https://ClinicalTrials.gov/show/NCT00195299 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00188253 Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT00188253 Active, not recruiting University Health Network, Toronto 2017-02-28
NCT00178867 A National Registry of Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00178867 Completed Vanderbilt University NA
NCT00165126 Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT00165126 Completed Dana-Farber Cancer Institute 2006-01-31
NCT00160095 Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas https://ClinicalTrials.gov/show/NCT00160095 Completed Radboud University 2010-03-31
NCT00148213 Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00148213 Completed University Hospital Muenster NA
NCT00026663 Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance https://ClinicalTrials.gov/show/NCT00026663 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00540566 Optical Biopsy of Human Skin in Conjunction With Laser Treatment https://ClinicalTrials.gov/show/NCT00540566 Completed University of California, Irvine 2008-06-30
NCT00836342 Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer https://ClinicalTrials.gov/show/NCT00836342 Completed Massachusetts General Hospital 2012-01-31
NCT00716625 Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan) https://ClinicalTrials.gov/show/NCT00716625 Completed Pfizer 2015-10-31
NCT00005660 The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases https://ClinicalTrials.gov/show/NCT00005660 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001603 The Effects of Upper Airway and Digestive Tract Tumors on the Immune System https://ClinicalTrials.gov/show/NCT00001603 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03374267 Registry Platform Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03374267 Recruiting iOMEDICO AG 2024-12-31
NCT03124394 Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study https://ClinicalTrials.gov/show/NCT03124394 Recruiting Kantonsspital Winterthur KSW 2020-12-31
NCT02908048 Extracellular RNA Markers of Liver Disease and Cancer https://ClinicalTrials.gov/show/NCT02908048 Active, not recruiting Mayo Clinic 2021-07-31
NCT02789137 Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment https://ClinicalTrials.gov/show/NCT02789137 Active, not recruiting Pfizer 2020-09-30
NCT02689609 Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02689609 Completed The University of Hong Kong 2013-12-31
NCT02551250 Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02551250 Active, not recruiting Seoul St. Mary’s Hospital 2019-12-31
NCT02310503 Spanish Registry of Mohs Surgery https://ClinicalTrials.gov/show/NCT02310503 Completed Fundación Academia Española de Dermatología 2020-02-29
NCT02082886 HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis ‐ Data Registry https://ClinicalTrials.gov/show/NCT02082886 Completed Edward-Elmhurst Health System 2020-01-31
NCT02073500 Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies https://ClinicalTrials.gov/show/NCT02073500 Recruiting Oslo University Hospital 2017-01-31
NCT02025842 Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02025842 Completed Azienda Ospedaliera San Camillo Forlanini 2013-12-31
NCT01891539 Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01891539 Recruiting International Group of Endovascular Oncology 2021-09-30
NCT01890291 Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients. https://ClinicalTrials.gov/show/NCT01890291 Completed Green Cross Cell Corporation 2016-01-31
NCT01511393 An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) https://ClinicalTrials.gov/show/NCT01511393 Enrolling by invitation United BioSource, LLC 2035-12-31
NCT04122937 Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer. https://ClinicalTrials.gov/show/NCT04122937 Completed University of Pisa 2018-06-01
NCT04108338 Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04108338 Completed Sun Yat-sen University 2019-07-01
NCT04069468 Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT04069468 Recruiting Biocompatibles UK Ltd 2024-01-01
NCT03956836 Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) https://ClinicalTrials.gov/show/NCT03956836 Recruiting Hospitales Universitarios Virgen del Rocío 2020-10-31
NCT03955393 FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS https://ClinicalTrials.gov/show/NCT03955393 Active, not recruiting IRCCS San Raffaele 2019-04-30
NCT03775798 Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV. https://ClinicalTrials.gov/show/NCT03775798 Recruiting Austral University, Argentina 2020-12-01
NCT03669952 Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer https://ClinicalTrials.gov/show/NCT03669952 Completed Omphis Foundation 2015-12-31
NCT03630536 TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative https://ClinicalTrials.gov/show/NCT03630536 Recruiting Children’s Hospital Medical Center, Cincinnati 2028-05-31
NCT03546998 Epidermoid Cancer Development in Esophageal Achalasia https://ClinicalTrials.gov/show/NCT03546998 Recruiting University of Bologna 2025-12-31
NCT03544437 Feasibility and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT03544437 Recruiting RenJi Hospital 2018-12-30
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://ClinicalTrials.gov/show/NCT03452774 Recruiting Massive Bio, Inc. 2021-12-31
NCT04085900 Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City https://ClinicalTrials.gov/show/NCT04085900 Recruiting Zhongshan People’s Hospital, Guangdong, China 2029-09-30
NCT00610012 Tumor Registry of Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00610012 Completed iOMEDICO AG 2020-05-15
NCT00457587 Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma https://ClinicalTrials.gov/show/NCT00457587 Active, not recruiting University of Wuerzburg 2011-12-31